| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SH3 domain binding | DOCK4 CTTNBP2 SIRPA SYNJ1 ADAM17 SHANK1 SH3BP2 NCKIPSD RAPGEF1 PRRT2 DENND1A SOS1 | 1.04e-08 | 143 | 187 | 12 | GO:0017124 |
| GeneOntologyMolecularFunction | protein domain specific binding | DOCK4 CTTNBP2 SIRPA SYNJ1 TJP2 ADAM17 SHANK1 CACNA1D SH3BP2 NCKIPSD RAPGEF1 E2F4 SRCIN1 PRRT2 PIAS2 DENND1A KLF1 TJP1 RIMS2 SRRM2 SOS1 | 7.52e-05 | 875 | 187 | 21 | GO:0019904 |
| GeneOntologyMolecularFunction | chromatin binding | TOX MAZ PHF8 KDM6B REPIN1 CIC PYGO2 HSF1 MNT TICRR ZEB1 E2F4 BAHD1 PBRM1 ASXL3 H1-3 ANKRD17 CUX1 | 2.10e-04 | 739 | 187 | 18 | GO:0003682 |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | DOCK4 DENND1C ARHGEF17 CHRM4 RAPGEF1 DENND1A KNDC1 FGD6 SOS1 | 3.39e-04 | 231 | 187 | 9 | GO:0005085 |
| GeneOntologyCellularComponent | ribbon synapse | 1.02e-05 | 32 | 192 | 5 | GO:0097470 | |
| GeneOntologyCellularComponent | actin cytoskeleton | CTTNBP2 MYLK MYO9B SEPTIN9 TMOD4 SYNPO BIN2 ADAM17 AMPH CARMIL1 BAG3 SRCIN1 GAS2L2 TJP1 SH3PXD2A MYO15A PPP1R12C | 2.47e-05 | 576 | 192 | 17 | GO:0015629 |
| GeneOntologyCellularComponent | dendrite | CTTNBP2 MAP1A MPDZ SYNPO CHRM4 CHRNA4 PTK2B C4A C4B SHANK1 CACNA1D PCLO SRCIN1 UBXN1 PRRT2 GRM1 DENND1A RPH3A KNDC1 MAST1 | 1.30e-04 | 858 | 192 | 20 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | CTTNBP2 MAP1A MPDZ SYNPO CHRM4 CHRNA4 PTK2B C4A C4B SHANK1 CACNA1D PCLO SRCIN1 UBXN1 PRRT2 GRM1 DENND1A RPH3A KNDC1 MAST1 | 1.34e-04 | 860 | 192 | 20 | GO:0097447 |
| GeneOntologyCellularComponent | contractile actin filament bundle | 4.65e-04 | 107 | 192 | 6 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 4.65e-04 | 107 | 192 | 6 | GO:0001725 | |
| GeneOntologyCellularComponent | primary dendrite | 4.97e-04 | 4 | 192 | 2 | GO:0150001 | |
| GeneOntologyCellularComponent | photoreceptor ribbon synapse | 5.62e-04 | 18 | 192 | 3 | GO:0098684 | |
| GeneOntologyCellularComponent | actomyosin | 7.47e-04 | 117 | 192 | 6 | GO:0042641 | |
| GeneOntologyCellularComponent | actin filament bundle | 7.81e-04 | 118 | 192 | 6 | GO:0032432 | |
| GeneOntologyCellularComponent | cholinergic synapse | 1.03e-03 | 22 | 192 | 3 | GO:0098981 | |
| GeneOntologyCellularComponent | supramolecular fiber | MYBPH MAP1A MYO9B SEPTIN9 TMOD4 ZNF207 SYNPO CLIP1 BFSP1 SYNJ1 KIF2A CACNA1D REM1 CARMIL1 BAG3 NCKIPSD COL5A3 STMN1 FAM83H GAS2L2 PDE4DIP CEP170B | 1.26e-03 | 1179 | 192 | 22 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MYBPH MAP1A MYO9B SEPTIN9 TMOD4 ZNF207 SYNPO CLIP1 BFSP1 SYNJ1 KIF2A CACNA1D REM1 CARMIL1 BAG3 NCKIPSD COL5A3 STMN1 FAM83H GAS2L2 PDE4DIP CEP170B | 1.37e-03 | 1187 | 192 | 22 | GO:0099081 |
| GeneOntologyCellularComponent | presynapse | CTTNBP2 CHRM4 CHRNA4 PTK2B BRAF SYNJ1 ARFGAP3 CNGB1 GPR151 CACNA1D AMPH PCLO SRCIN1 PRRT2 GRM1 DENND1A RPH3A RIMS2 | 1.40e-03 | 886 | 192 | 18 | GO:0098793 |
| Domain | NPIP | 1.87e-07 | 14 | 189 | 5 | IPR009443 | |
| Domain | SH3 | DOCK4 PRAM1 TJP2 PLCG2 SHANK1 AMPH NCKIPSD SLA SH3D21 TJP1 SH3PXD2A MYO15A | 2.13e-06 | 216 | 189 | 12 | SM00326 |
| Domain | SH3 | DOCK4 PRAM1 TJP2 PLCG2 SHANK1 AMPH NCKIPSD SLA SH3D21 TJP1 SH3PXD2A MYO15A | 2.13e-06 | 216 | 189 | 12 | PS50002 |
| Domain | SH3_domain | DOCK4 PRAM1 TJP2 PLCG2 SHANK1 AMPH NCKIPSD SLA SH3D21 TJP1 SH3PXD2A MYO15A | 2.58e-06 | 220 | 189 | 12 | IPR001452 |
| Domain | Znf_FYVE_PHD | 1.91e-05 | 147 | 189 | 9 | IPR011011 | |
| Domain | SH3_2 | 2.66e-05 | 86 | 189 | 7 | PF07653 | |
| Domain | SH3_2 | 2.66e-05 | 86 | 189 | 7 | IPR011511 | |
| Domain | PDZ | 1.54e-04 | 151 | 189 | 8 | PS50106 | |
| Domain | PDZ | 1.61e-04 | 152 | 189 | 8 | IPR001478 | |
| Domain | DUF4599 | 2.10e-04 | 12 | 189 | 3 | PF15371 | |
| Domain | DUF4599 | 2.10e-04 | 12 | 189 | 3 | IPR027970 | |
| Domain | ZO | 3.04e-04 | 3 | 189 | 2 | IPR005417 | |
| Domain | Amphiphysin | 3.04e-04 | 3 | 189 | 2 | IPR003005 | |
| Domain | Calcipressin | 3.04e-04 | 3 | 189 | 2 | IPR006931 | |
| Domain | Calcipressin | 3.04e-04 | 3 | 189 | 2 | PF04847 | |
| Domain | ZF_PHD_2 | 4.09e-04 | 95 | 189 | 6 | PS50016 | |
| Domain | ZF_PHD_1 | 4.32e-04 | 96 | 189 | 6 | PS01359 | |
| Domain | AT_hook | 5.18e-04 | 16 | 189 | 3 | PF02178 | |
| Domain | PDZ | 5.87e-04 | 141 | 189 | 7 | PF00595 | |
| Domain | DUF1908 | 6.03e-04 | 4 | 189 | 2 | PF08926 | |
| Domain | MA_Ser/Thr_Kinase_dom | 6.03e-04 | 4 | 189 | 2 | IPR015022 | |
| Domain | MAST_pre-PK_dom | 6.03e-04 | 4 | 189 | 2 | IPR023142 | |
| Domain | - | 6.03e-04 | 4 | 189 | 2 | 1.20.1480.20 | |
| Domain | C345C | 6.25e-04 | 17 | 189 | 3 | SM00643 | |
| Domain | PDZ | 7.83e-04 | 148 | 189 | 7 | SM00228 | |
| Domain | - | 8.47e-04 | 150 | 189 | 7 | 2.30.42.10 | |
| Domain | NTR | 8.77e-04 | 19 | 189 | 3 | PF01759 | |
| Domain | Netrin_module_non-TIMP | 8.77e-04 | 19 | 189 | 3 | IPR018933 | |
| Domain | PHD | 9.79e-04 | 75 | 189 | 5 | PF00628 | |
| Domain | Anaphylatoxin_comp_syst | 9.98e-04 | 5 | 189 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 9.98e-04 | 5 | 189 | 2 | IPR001840 | |
| Domain | RasGEFN | 1.02e-03 | 20 | 189 | 3 | SM00229 | |
| Domain | RasGEF_N | 1.19e-03 | 21 | 189 | 3 | PF00618 | |
| Domain | Znf_PHD-finger | 1.24e-03 | 79 | 189 | 5 | IPR019787 | |
| Domain | Ras-like_Gua-exchang_fac_N | 1.36e-03 | 22 | 189 | 3 | IPR000651 | |
| Domain | RASGEF_NTER | 1.36e-03 | 22 | 189 | 3 | PS50212 | |
| Domain | E2F_CC-MB | 1.49e-03 | 6 | 189 | 2 | IPR032198 | |
| Domain | SPOC_C | 1.49e-03 | 6 | 189 | 2 | IPR012921 | |
| Domain | E2F_CC-MB | 1.49e-03 | 6 | 189 | 2 | PF16421 | |
| Domain | SPOC | 1.49e-03 | 6 | 189 | 2 | PF07744 | |
| Domain | NTR | 1.56e-03 | 23 | 189 | 3 | PS50189 | |
| Domain | Netrin_domain | 1.56e-03 | 23 | 189 | 3 | IPR001134 | |
| Domain | - | 1.88e-03 | 52 | 189 | 4 | 2.60.120.290 | |
| Domain | CUB | 2.02e-03 | 53 | 189 | 4 | PS01180 | |
| Domain | HMG_box | 2.02e-03 | 53 | 189 | 4 | PF00505 | |
| Domain | ANATO | 2.07e-03 | 7 | 189 | 2 | SM00104 | |
| Domain | zf-MIZ | 2.07e-03 | 7 | 189 | 2 | PF02891 | |
| Domain | ZF_SP_RING | 2.07e-03 | 7 | 189 | 2 | PS51044 | |
| Domain | ANAPHYLATOXIN_2 | 2.07e-03 | 7 | 189 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 2.07e-03 | 7 | 189 | 2 | PS01177 | |
| Domain | ANATO | 2.07e-03 | 7 | 189 | 2 | PF01821 | |
| Domain | Anaphylatoxin/fibulin | 2.07e-03 | 7 | 189 | 2 | IPR000020 | |
| Domain | PHD | 2.10e-03 | 89 | 189 | 5 | SM00249 | |
| Domain | - | BRPF3 RNF13 PHF8 KMT2C PYGO2 PCLO ZMIZ1 PIAS2 RPH3A PHF3 RIMS2 FGD6 | 2.13e-03 | 449 | 189 | 12 | 3.30.40.10 |
| Domain | HMG | 2.16e-03 | 54 | 189 | 4 | SM00398 | |
| Domain | C2 | 2.18e-03 | 131 | 189 | 6 | PF00168 | |
| Domain | RASGEF | 2.23e-03 | 26 | 189 | 3 | PS00720 | |
| Domain | TIMP-like_OB-fold | 2.23e-03 | 26 | 189 | 3 | IPR008993 | |
| Domain | Bromodomain_CS | 2.23e-03 | 26 | 189 | 3 | IPR018359 | |
| Domain | Znf_PHD | 2.32e-03 | 91 | 189 | 5 | IPR001965 | |
| Domain | Znf_RING/FYVE/PHD | BRPF3 RNF13 PHF8 KMT2C PYGO2 PCLO ZMIZ1 PIAS2 RPH3A PHF3 RIMS2 FGD6 | 2.55e-03 | 459 | 189 | 12 | IPR013083 |
| Domain | CUB_dom | 2.64e-03 | 57 | 189 | 4 | IPR000859 | |
| Domain | C2 | 2.73e-03 | 137 | 189 | 6 | SM00239 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 2.74e-03 | 8 | 189 | 2 | IPR019565 | |
| Domain | E2F | 2.74e-03 | 8 | 189 | 2 | IPR015633 | |
| Domain | Thiol-ester_cl | 2.74e-03 | 8 | 189 | 2 | PF10569 | |
| Domain | Znf_MIZ | 2.74e-03 | 8 | 189 | 2 | IPR004181 | |
| Domain | MacrogloblnA2_CS | 2.74e-03 | 8 | 189 | 2 | IPR019742 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DOCK4 MAZ MPDZ CC2D1A ARHGEF17 CIC LUZP1 PTK2B MAST4 BRAF SYNJ1 PRRC2C PI4KA TJP2 HELZ KIF2A CARMIL1 BAG3 NCKIPSD DENND1A FAM83H C6orf132 MAP7D1 TJP1 SH3PXD2A PHF3 ANKRD17 SRRM2 FGD6 CEP170B PPP1R12C | 2.60e-16 | 861 | 197 | 31 | 36931259 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MYO9B CDK12 CC2D1A KDM6B TRRAP REPIN1 CHRM4 REXO1 CIC KMT2C PER2 TULP4 SYNJ1 RBM19 PI4KA ZNF398 SNX15 WNK2 FAM193B RHBDF2 RAPGEF1 GTF2IRD1 DENND1A BAHD1 C8orf58 FAM83H C6orf132 SCAP PCNX4 LTK SPEN CEP170B | 3.49e-14 | 1105 | 197 | 32 | 35748872 |
| Pubmed | CDK12 MPDZ CC2D1A TNIP1 POGZ PHF8 TRRAP LUZP1 KMT2C SYNJ1 PRRC2C NFRKB TJP2 BAG3 PTPN23 STMN1 CHAMP1 SETD2 TJP1 PHF3 MDC1 SPEN CUX1 | 1.09e-13 | 549 | 197 | 23 | 38280479 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | CDK12 SEPTIN9 POGZ PHF8 TRRAP CLIP1 REXO1 CIC BRAF NFRKB TJP2 HELZ HSF1 ZEB1 CARMIL1 BAG3 GTF2IRD1 CHAMP1 SETD2 PHF3 MDC1 ANKRD17 SRRM2 SPEN PRG4 SOS1 | 3.97e-13 | 774 | 197 | 26 | 15302935 |
| Pubmed | BRPF3 MAP1A ATXN7L1 MAZ KPNA6 POGZ PHF8 TRRAP REPIN1 LUZP1 ZNF469 NFRKB HELZ ADAM17 KNL1 ZNF574 CECR2 SH3BP2 CHAMP1 FAM83H SETD2 MAP7D1 PBRM1 LBX1 ANKRD17 LTK SRRM2 CEP170B SOS1 | 8.77e-12 | 1116 | 197 | 29 | 31753913 | |
| Pubmed | CTTNBP2 MAP1A SEPTIN9 SYNPO ARHGEF17 LUZP1 PTK2B GJA3 SYNJ1 PRRC2C PI4KA TJP2 C4A C4B KIF2A WNK2 SHANK1 AMPH CARMIL1 PCLO NCKIPSD SRCIN1 GRM1 RPH3A MAP7D1 TJP1 PDE4DIP H1-3 KNDC1 MAST1 CEP170B PPP1R12C | 3.22e-11 | 1431 | 197 | 32 | 37142655 | |
| Pubmed | ZNF142 MAP1A KPNA6 SYNPO POGZ CIC KMT2C BRAF HELZ C4A WNK2 SHANK1 BAG3 RAPGEF1 PTPN23 PIAS2 ANKRD17 CUX1 SOS1 | 5.45e-11 | 486 | 197 | 19 | 20936779 | |
| Pubmed | BRPF3 CDK12 NACA SYNPO POGZ KDM6B KMT2C MAST4 CPNE1 WNK2 SDK2 CECR2 SRCIN1 CHAMP1 BAHD1 MDC1 SETBP1 ANKRD17 RIMS2 | 2.28e-10 | 529 | 197 | 19 | 14621295 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | MAP1A SYNPO LUZP1 PTK2B SYNJ1 PI4KA SHANK1 AMPH PCLO SRCIN1 GRM1 PHF3 RIMS2 CEP170B | 9.27e-10 | 281 | 197 | 14 | 28706196 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | MAZ POGZ CEP76 GMPS KMT2C HOXB2 BRAF SYNJ1 NFRKB ZEB1 CECR2 PCLO NCKIPSD PBRM1 MYO15A CUX1 | 1.28e-09 | 398 | 197 | 16 | 35016035 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | MAP1A CIC TASOR2 ZNF469 PRR14 TULP4 NYAP1 WNK2 GRM1 SH3D21 C6orf132 MDC1 SETBP1 INAVA SPEN SOS1 | 3.87e-09 | 430 | 197 | 16 | 35044719 |
| Pubmed | CTTNBP2 NPIPB12 MYO9B SEPTIN9 ZNF207 REPIN1 TASOR2 PYGO2 ADAM17 USP35 MNT TICRR FAM193B CHERP CARMIL1 RAPGEF1 PRR22 E2F5 CHAMP1 SH3D21 FAM83H SCAP TJP1 SH3PXD2A RIMS2 CEP170B | 6.77e-09 | 1215 | 197 | 26 | 15146197 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ATXN7L1 SEPTIN9 SYNPO TRRAP TASOR2 GMPS KMT2C TULP4 WNK2 RHBDF2 CARMIL1 SH3BP2 APBB2 STAP2 SRCIN1 ZMIZ1 GTF2IRD1 DENND1A TJP1 SH3PXD2A PCNX4 SETBP1 KNDC1 MAST1 ZFHX2 ANKRD17 TMEM143 CEP170B CUX1 | 6.84e-09 | 1489 | 197 | 29 | 28611215 |
| Pubmed | CTTNBP2 MPDZ SYNPO SIRPA CLIP1 LUZP1 SYNJ1 PRRC2C PI4KA KIF2A WNK2 SHANK1 ZEB1 GRM1 RPH3A MAP7D1 PBRM1 TJP1 PDE4DIP DCHS1 ANKRD17 CEP170B CUX1 | 7.26e-09 | 963 | 197 | 23 | 28671696 | |
| Pubmed | 7.27e-09 | 102 | 197 | 9 | 11214970 | ||
| Pubmed | SPATA31D4 SPATA31D3 KMT2C NYNRIN HSF1 WNK2 MAP7D1 PHF3 PDE4DIP MAST1 LTK SRRM2 | 1.05e-08 | 233 | 197 | 12 | 37704626 | |
| Pubmed | DOCK4 SEPTIN9 POGZ PHF8 ARHGEF17 SEMA6D PER2 PRRC2C MAP7D1 PHF3 PDE4DIP MAST1 SRRM2 SPEN CEP170B | 1.37e-08 | 407 | 197 | 15 | 12693553 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | CDK12 SEPTIN9 MAZ ZNF207 POGZ CIC LUZP1 TASOR2 PRAM1 PRRC2C RBM19 NFRKB KNL1 CHERP CHAMP1 SETD2 TJP1 PHF3 MDC1 SRRM2 SPEN CUX1 | 2.93e-08 | 954 | 197 | 22 | 36373674 |
| Pubmed | CDK12 MAZ NACA MPDZ ZNF207 TRRAP REPIN1 CIC LUZP1 KMT2C ARFGAP3 RBM19 PI4KA NFRKB HELZ KIF2A ZNF574 DENND1A C6orf132 SETD2 MAP7D1 PBRM1 PHF3 MDC1 ANKRD17 SPEN CEP170B PPP1R12C | 3.02e-08 | 1497 | 197 | 28 | 31527615 | |
| Pubmed | CDK12 SEPTIN9 CC2D1A TNIP1 CLIP1 PYGO2 BRAF TJP2 ZNF574 BAG3 STMN1 CHAMP1 PBRM1 PHF3 SRRM2 SPEN | 3.46e-08 | 503 | 197 | 16 | 16964243 | |
| Pubmed | DOCK4 MAP1A SEPTIN9 NACA SYNPO GMPS SYNJ1 ARFGAP3 PRRC2C PI4KA TJP2 HELZ KIF2A WNK2 SHANK1 AMPH PCLO SRCIN1 STMN1 RPH3A TJP1 PDE4DIP KNDC1 CEP170B | 3.62e-08 | 1139 | 197 | 24 | 36417873 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | DOCK4 MAP1A MYO9B TNIP1 KPNA6 CIC LUZP1 SYNJ1 PRRC2C PI4KA HELZ KNL1 ZNF574 PIAS2 SETD2 SPEN CEP170B | 5.06e-08 | 588 | 197 | 17 | 38580884 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MAP1A CDK12 SEPTIN9 NACA CC2D1A CIC GMPS SYNJ1 PRRC2C HELZ KNL1 FAM193B CHERP CARMIL1 BAG3 PTPN23 STMN1 CHAMP1 SETD2 TJP1 ANKRD17 | 9.42e-08 | 934 | 197 | 21 | 33916271 |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | MAP1A SYNPO LUZP1 PTK2B TJP2 PCLO SRCIN1 H1-3 RIMS2 SRRM2 CEP170B | 9.69e-08 | 231 | 197 | 11 | 16452087 |
| Pubmed | TNIP1 POGZ CIC LUZP1 SYNJ1 KNL1 ZEB1 BAG3 ZMIZ1 CHAMP1 PIAS2 MAP7D1 ANKRD17 CUX1 | 1.37e-07 | 418 | 197 | 14 | 34709266 | |
| Pubmed | ATXN7L1 MAZ NACA CC2D1A TNIP1 POGZ PHF8 TRRAP CIC KMT2C PYGO2 PRRC2C NFRKB HELZ MNT ZEB1 STMN1 ZMIZ1 PIAS2 MAP7D1 PBRM1 MDC1 ANKRD17 SRRM2 SPEN CUX1 | 1.69e-07 | 1429 | 197 | 26 | 35140242 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | CDK12 PRRC2C RBM19 TJP2 SDK2 BAG3 CDCP1 MAP7D1 PHF3 ASXL3 MDC1 SRRM2 SPEN | 1.70e-07 | 361 | 197 | 13 | 26167880 |
| Pubmed | TMEM237 CDK12 SEPTIN9 MAZ NACA ZNF207 CC2D1A POGZ CLIP1 REPIN1 LUZP1 BRAF PRRC2C RBM19 TJP2 CPNE1 C4B ZNF574 SMARCAL1 DENND1A MAP7D1 PBRM1 TJP1 PHF3 ANKRD17 | 2.86e-07 | 1371 | 197 | 25 | 36244648 | |
| Pubmed | CTTNBP2 MPDZ CLIP1 LUZP1 BRAF NYNRIN TJP2 HELZ KIF2A NCKIPSD DENND1A TJP1 SH3PXD2A CEP170B | 2.99e-07 | 446 | 197 | 14 | 24255178 | |
| Pubmed | SEPTIN9 ZNF207 CC2D1A POGZ TRRAP CIC GMPS PRAM1 KMT2C PRRC2C NFRKB CPNE1 BIN2 KIF2A MNT KNL1 STMN1 UBXN1 MAP7D1 SRRM2 SPEN CUX1 | 3.55e-07 | 1103 | 197 | 22 | 34189442 | |
| Pubmed | BRPF3 MYLK TULP4 PLCG2 WNK2 NCKIPSD RAPGEF1 GTF2IRD1 RIMS2 SPEN PRG4 SOS1 | 4.47e-07 | 329 | 197 | 12 | 17474147 | |
| Pubmed | CDK12 NACA CLIP1 PRAM1 CHERP CECR2 PCLO ZMIZ1 MAP7D1 PBRM1 MDC1 H1-3 SPEN | 4.85e-07 | 396 | 197 | 13 | 26687479 | |
| Pubmed | 7.05e-07 | 225 | 197 | 10 | 12168954 | ||
| Pubmed | The ZEB1/miR-200c feedback loop regulates invasion via actin interacting proteins MYLK and TKS5. | 7.13e-07 | 4 | 197 | 3 | 26334100 | |
| Pubmed | MAP1A CDK12 SEPTIN9 CLIP1 SYNJ1 TJP2 SNX15 STMN1 GTF2IRD1 TJP1 | 7.34e-07 | 226 | 197 | 10 | 31452512 | |
| Pubmed | MAP1A SYNPO SYNJ1 CPNE1 PCLO SRCIN1 STMN1 SH3PXD2A RIMS2 SRRM2 CEP170B SOS1 | 7.84e-07 | 347 | 197 | 12 | 17114649 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | SEPTIN9 CC2D1A SIRPA LUZP1 SYNJ1 PI4KA TJP2 ADAM17 CARMIL1 BAG3 SRCIN1 FAM83H C6orf132 TJP1 INAVA | 9.27e-07 | 565 | 197 | 15 | 25468996 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MAP1A SEPTIN9 MAZ CC2D1A POGZ LUZP1 PRRC2C RBM19 TJP2 HELZ STMN1 MAP7D1 TJP1 SH3PXD2A PHF3 ANKRD17 SPEN | 9.30e-07 | 724 | 197 | 17 | 36232890 |
| Pubmed | Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder. | 9.56e-07 | 14 | 197 | 4 | 28263302 | |
| Pubmed | POGZ TRRAP TASOR2 GMPS PRRC2C TJP2 HELZ CHERP PBRM1 TJP1 PHF3 MDC1 H1-3 ANKRD17 SRRM2 SPEN | 1.14e-06 | 653 | 197 | 16 | 22586326 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | TMEM237 MAZ ZKSCAN8 POGZ PHF8 TRRAP CIC KMT2C NFRKB MNT TICRR CHERP MED9 GTF2IRD1 CHAMP1 SETD2 MAP7D1 PBRM1 PHF3 MDC1 SRRM2 SPEN CUX1 | 1.37e-06 | 1294 | 197 | 23 | 30804502 |
| Pubmed | NACA CC2D1A TRRAP CLIP1 GMPS PI4KA PLCG2 HSF1 CHERP PTPN23 SETD2 SCAP PCNX4 MDC1 H1-3 DCHS1 RIMS2 | 1.61e-06 | 754 | 197 | 17 | 35906200 | |
| Pubmed | DOCK4 SEPTIN9 ZNF207 SYNPO ZC3H6 CIC KMT2C SYNJ1 NPIPB11 NCKIPSD TUT1 SRCIN1 PIAS2 PHF3 PDE4DIP FGD6 | 2.27e-06 | 689 | 197 | 16 | 36543142 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | MAZ ZKSCAN8 SYNPO POGZ PHF8 TRRAP CIC NFRKB CHAMP1 PIAS2 PBRM1 PHF3 MDC1 SPEN CUX1 | 2.28e-06 | 608 | 197 | 15 | 36089195 |
| Pubmed | 3.40e-06 | 268 | 197 | 10 | 33640491 | ||
| Pubmed | Piccolo, a presynaptic zinc finger protein structurally related to bassoon. | 3.54e-06 | 6 | 197 | 3 | 10707984 | |
| Pubmed | 3.54e-06 | 6 | 197 | 3 | 19506035 | ||
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | MYO9B CDK12 ZKSCAN8 CHRM4 CIC FAM193B RHBDF2 CARMIL1 ZMIZ1 SH3D21 TJP1 ASXL3 PDE4DIP ZFHX2 | 3.66e-06 | 552 | 197 | 14 | 10737800 |
| Pubmed | TOX ZKSCAN8 ZNF207 POGZ PHF8 ZC3H6 CIC PRR14 ZNF398 HSF1 MNT ZEB1 E2F4 E2F5 PIAS2 PBRM1 CUX1 | 4.05e-06 | 808 | 197 | 17 | 20412781 | |
| Pubmed | 4.65e-06 | 116 | 197 | 7 | 30804394 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | POGZ KMT2C PYGO2 NFRKB ZEB1 ZMIZ1 PIAS2 PBRM1 ASXL3 MDC1 SPEN | 5.83e-06 | 351 | 197 | 11 | 38297188 |
| Pubmed | CDK12 MAZ NACA ZNF207 CIC NFRKB KIF2A ZEB1 CECR2 PCLO BAG3 H1-3 | 6.31e-06 | 425 | 197 | 12 | 24999758 | |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 7.74e-06 | 232 | 197 | 9 | 25515538 | |
| Pubmed | DOCK4 CTTNBP2 TRRAP REPIN1 KMT2C BRAF ZNF398 AMPH PCLO GTF2IRD1 POM121B CUX1 | 9.15e-06 | 441 | 197 | 12 | 12853948 | |
| Pubmed | EKLF/KLF1 controls cell cycle entry via direct regulation of E2f2. | 9.82e-06 | 8 | 197 | 3 | 19457859 | |
| Pubmed | ZNF207 LUZP1 KIF2A KNL1 ZEB1 MED9 GTF2IRD1 CHAMP1 FAM83H SETD2 PHF3 MDC1 | 1.20e-05 | 453 | 197 | 12 | 29656893 | |
| Pubmed | 1.23e-05 | 187 | 197 | 8 | 26460568 | ||
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | MYO9B CC2D1A POGZ PHF8 TRRAP NFRKB KIF2A MED9 PBRM1 PCNX4 MDC1 H1-3 SRRM2 | 1.24e-05 | 533 | 197 | 13 | 30554943 |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | CDK12 ZNF207 KPNA6 CIC KMT2C PRR14 PYGO2 PRRC2C HELZ ZMIZ1 FAM83H ANKRD17 | 1.30e-05 | 457 | 197 | 12 | 32344865 |
| Pubmed | MAP1A CDK12 NACA ZNF207 CLIP1 CIC KNL1 PTPN23 CHAMP1 PHF3 SRRM2 CUX1 | 1.79e-05 | 472 | 197 | 12 | 38943005 | |
| Pubmed | 1.80e-05 | 197 | 197 | 8 | 36604605 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | ZNF142 TMEM237 CDK12 MAZ ZKSCAN8 POGZ SIRPA REPIN1 ADAM17 MNT ZNF574 SHANK1 ZEB1 CHERP CHAMP1 PIAS2 PBRM1 TJP1 PHF3 SRRM2 | 1.84e-05 | 1203 | 197 | 20 | 29180619 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | CTTNBP2 MAZ MPDZ ZNF207 TRRAP GMPS NFRKB TJP2 CPNE1 BAG3 E2F5 TUT1 UBXN1 MAP7D1 TJP1 ANKRD17 SRRM2 DEDD | 1.86e-05 | 1005 | 197 | 18 | 19615732 |
| Pubmed | 2.09e-05 | 10 | 197 | 3 | 19071123 | ||
| Pubmed | CDK12 NACA MPDZ ARFGAP3 NFRKB TJP2 HELZ KNL1 CHERP RCAN3 SETD2 SCAP TJP1 PHF3 MDC1 | 2.10e-05 | 733 | 197 | 15 | 34672954 | |
| Pubmed | ADAM10 hyperactivation acts on piccolo to deplete synaptic vesicle stores in Huntington's disease. | 2.15e-05 | 202 | 197 | 8 | 33601422 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 2.65e-05 | 208 | 197 | 8 | 33230847 | |
| Pubmed | 2.77e-05 | 103 | 197 | 6 | 21706016 | ||
| Pubmed | 2.93e-05 | 104 | 197 | 6 | 9205841 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | SEPTIN9 KPNA6 CEP76 TRRAP KMT2C TJP2 C4A C4B KIF2A CARMIL1 SRCIN1 MAP7D1 | 2.97e-05 | 497 | 197 | 12 | 36774506 |
| Pubmed | MYO9B SEPTIN9 ZC3H6 REPIN1 LUZP1 GMPS BRAF TULP4 KIF2A MED9 BAG3 SIM2 FAM83H TJP1 PHF3 H1-3 ANKRD17 INAVA SRRM2 CUX1 | 3.05e-05 | 1247 | 197 | 20 | 27684187 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYO9B SEPTIN9 NACA POGZ PHF8 TRRAP LUZP1 GMPS RBM19 PI4KA KIF2A PLCG2 BAG3 PTPN23 UBXN1 FAM83H SMG8 MAP7D1 MDC1 ANKRD17 SRRM2 | 3.08e-05 | 1353 | 197 | 21 | 29467282 |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 3.19e-05 | 2 | 197 | 2 | 16565498 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 15998580 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 29045841 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 19062096 | ||
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 3.19e-05 | 2 | 197 | 2 | 19933335 | |
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 3.19e-05 | 2 | 197 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 3.19e-05 | 2 | 197 | 2 | 17645767 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 12207352 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 3.19e-05 | 2 | 197 | 2 | 27758680 | |
| Pubmed | The zonula occludens protein family regulates the hepatic barrier system in the murine liver. | 3.19e-05 | 2 | 197 | 2 | 33184034 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 22387014 | ||
| Pubmed | Isoform-selective interaction of the adaptor protein Tks5/FISH with Sos1 and dynamins. | 3.19e-05 | 2 | 197 | 2 | 19464300 | |
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 3.19e-05 | 2 | 197 | 2 | 23749435 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 23918728 | ||
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 3.19e-05 | 2 | 197 | 2 | 3037333 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 11726230 | ||
| Pubmed | Emerging roles of rhomboid-like pseudoproteases in inflammatory and innate immune responses. | 3.19e-05 | 2 | 197 | 2 | 28815577 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 4216347 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 19199833 | ||
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 3.19e-05 | 2 | 197 | 2 | 6950384 | |
| Pubmed | ZO-1- and ZO-2-dependent integration of myosin-2 to epithelial zonula adherens. | 3.19e-05 | 2 | 197 | 2 | 18596233 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 20404178 | ||
| Pubmed | The iRhom2/ADAM17 Axis Attenuates Bacterial Uptake by Phagocytes in a Cell Autonomous Manner. | 3.19e-05 | 2 | 197 | 2 | 32825187 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 8660986 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 3.19e-05 | 2 | 197 | 2 | 8428773 | |
| Pubmed | The EMT factor ZEB1 paradoxically inhibits EMT in BRAF-mutant carcinomas. | 3.19e-05 | 2 | 197 | 2 | 37870961 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 24638111 | ||
| Interaction | YWHAH interactions | DOCK4 MAZ MPDZ CC2D1A ARHGEF17 CIC CHRNA4 LUZP1 MAST4 BRAF SYNJ1 PRRC2C PI4KA TJP2 KIF2A WNK2 TICRR REM1 RHBDF2 CARMIL1 BAG3 NCKIPSD PIAS2 DENND1A RPH3A FAM83H C6orf132 MAP7D1 TJP1 SH3PXD2A PHF3 MAST1 ANKRD17 RIMS2 SRRM2 FGD6 CEP170B PPP1R12C | 3.17e-12 | 1102 | 191 | 38 | int:YWHAH |
| Interaction | MAPRE3 interactions | DOCK4 CTTNBP2 MAP1A MYO9B KLHDC7B CLIP1 LUZP1 MAST4 KIF2A C6orf132 MAP7D1 GAS2L2 PDE4DIP CEP170B | 4.35e-08 | 230 | 191 | 14 | int:MAPRE3 |
| Interaction | YWHAG interactions | DOCK4 CDK12 MAZ MPDZ SYNPO ARHGEF17 TRRAP CIC LUZP1 MAST4 BRAF SYNJ1 PRRC2C PI4KA TJP2 HELZ KIF2A TICRR CARMIL1 BAG3 NCKIPSD DENND1A FAM83H C6orf132 MAP7D1 TJP1 SH3PXD2A PHF3 ANKRD17 SRRM2 FGD6 CEP170B PPP1R12C | 7.58e-08 | 1248 | 191 | 33 | int:YWHAG |
| Interaction | TOP3B interactions | MYO9B CDK12 CC2D1A KDM6B TRRAP REPIN1 CHRM4 REXO1 CIC KMT2C PER2 TULP4 SYNJ1 RBM19 PI4KA ZNF398 HELZ SNX15 WNK2 FAM193B RHBDF2 RAPGEF1 GTF2IRD1 DENND1A BAHD1 C8orf58 FAM83H C6orf132 SCAP PCNX4 MDC1 ANKRD17 LTK SPEN CEP170B | 3.63e-07 | 1470 | 191 | 35 | int:TOP3B |
| Interaction | SFN interactions | MAP1A ARHGEF17 LUZP1 MAST4 BRAF PRRC2C TJP2 KIF2A CARMIL1 DENND1A FAM83H C6orf132 MAP7D1 TJP1 SH3PXD2A PHF3 H1-3 ANKRD17 SRRM2 FGD6 CEP170B PPP1R12C | 7.28e-07 | 692 | 191 | 22 | int:SFN |
| Interaction | TLE3 interactions | CDK12 ZNF207 CIC PYGO2 NFRKB HELZ KNL1 CHERP CECR2 ZMIZ1 FAM83H SETD2 SRRM2 SPEN CUX1 | 3.19e-06 | 376 | 191 | 15 | int:TLE3 |
| Interaction | BICD1 interactions | DOCK4 CC2D1A CLIP1 LUZP1 SYNJ1 ARFGAP3 TJP2 CARMIL1 NCKIPSD PTPN23 TJP1 CEP170B | 4.97e-06 | 250 | 191 | 12 | int:BICD1 |
| Interaction | AGAP2 interactions | MAP1A LUZP1 PTK2B SYNJ1 SHANK1 PCLO SRCIN1 GRM1 PHF3 RIMS2 CEP170B | 5.44e-06 | 210 | 191 | 11 | int:AGAP2 |
| Interaction | YWHAZ interactions | TNIP1 SYNPO CLIP1 CIC LUZP1 MAST4 PER2 BRAF TJP2 KIF2A HSF1 WNK2 TICRR REM1 BAG3 NCKIPSD DENND1A FAM83H C6orf132 MAP7D1 TJP1 SH3PXD2A PHF3 ASXL3 MDC1 MAST1 ANKRD17 FGD6 CEP170B PPP1R12C | 7.00e-06 | 1319 | 191 | 30 | int:YWHAZ |
| Interaction | TEAD1 interactions | 7.18e-06 | 176 | 191 | 10 | int:TEAD1 | |
| Interaction | YWHAE interactions | CDK12 TNIP1 CLIP1 CIC LUZP1 MAST4 PER2 BRAF TJP2 HSF1 SPINDOC WNK2 TICRR REM1 BAG3 NCKIPSD SRCIN1 UBXN1 DENND1A FAM83H C6orf132 MAP7D1 SH3PXD2A MAST1 ANKRD17 RIMS2 SRRM2 FGD6 CEP170B | 7.64e-06 | 1256 | 191 | 29 | int:YWHAE |
| Interaction | TRIM36 interactions | 9.67e-06 | 144 | 191 | 9 | int:TRIM36 | |
| Interaction | YWHAB interactions | DOCK4 ARHGEF17 TRRAP CIC LUZP1 MAST4 BRAF TJP2 KIF2A TICRR BAG3 NCKIPSD DENND1A FAM83H C6orf132 MAP7D1 TJP1 SH3PXD2A PHF3 MAST1 ANKRD17 SRRM2 FGD6 CEP170B PPP1R12C | 1.16e-05 | 1014 | 191 | 25 | int:YWHAB |
| Interaction | WWTR1 interactions | CDK12 MPDZ TNIP1 POGZ TRRAP LUZP1 SYNJ1 PRRC2C ZEB1 BAG3 PTPN23 SETD2 TJP1 PHF3 CUX1 | 1.27e-05 | 422 | 191 | 15 | int:WWTR1 |
| Interaction | CBX3 interactions | BRPF3 CDK12 KPNA6 POGZ KDM6B CIC PRR14 NFRKB KNL1 ZEB1 GTF2IRD1 CHAMP1 BAHD1 SETD2 PHF3 MDC1 SRRM2 SPEN CUX1 | 1.31e-05 | 646 | 191 | 19 | int:CBX3 |
| Interaction | FMR1 interactions | TNIP1 TRRAP LUZP1 PRRC2C KIF2A CECR2 BAG3 E2F4 SMG8 PBRM1 TJP1 ANKRD17 INAVA LTK CEP170B CUX1 PPP1R12C | 1.47e-05 | 536 | 191 | 17 | int:FMR1 |
| Interaction | PLEC interactions | CTTNBP2 MAP1A CDK12 SPEF2 NACA TNIP1 SYNPO PHF8 LUZP1 PER2 ARFGAP3 BAG3 TJP1 PDE4DIP SRRM2 | 1.59e-05 | 430 | 191 | 15 | int:PLEC |
| Interaction | PFN1 interactions | DOCK4 MAP1A MYO9B SEPTIN9 TNIP1 SIRPA SYNJ1 TJP2 KIF2A CARMIL1 PCLO BAG3 STMN1 C6orf132 TJP1 H1-3 | 2.94e-05 | 509 | 191 | 16 | int:PFN1 |
| Interaction | DCAF15 interactions | MAP1A CDK12 SEPTIN9 CLIP1 SYNJ1 TJP2 SNX15 ZEB1 STMN1 GTF2IRD1 TJP1 | 3.34e-05 | 255 | 191 | 11 | int:DCAF15 |
| Interaction | SOX9 interactions | 3.85e-05 | 97 | 191 | 7 | int:SOX9 | |
| Interaction | YAP1 interactions | CDK12 MPDZ CC2D1A POGZ PHF8 TRRAP LUZP1 KMT2C TULP4 PRRC2C NFRKB TJP2 SPINDOC ZEB1 BAG3 STMN1 CHAMP1 SH3D21 SETD2 TJP1 PHF3 MDC1 SRRM2 SPEN CUX1 | 4.17e-05 | 1095 | 191 | 25 | int:YAP1 |
| Interaction | KCTD13 interactions | CTTNBP2 MAP1A SEPTIN9 TNIP1 SYNPO ARHGEF17 LUZP1 PTK2B GJA3 SYNJ1 PRRC2C PI4KA TJP2 KIF2A WNK2 SHANK1 AMPH CARMIL1 PCLO NCKIPSD SRCIN1 GRM1 RPH3A MAP7D1 TJP1 KNDC1 MAST1 CEP170B PPP1R12C | 5.25e-05 | 1394 | 191 | 29 | int:KCTD13 |
| Interaction | DPPA4 interactions | 5.78e-05 | 140 | 191 | 8 | int:DPPA4 | |
| Interaction | LHX3 interactions | 7.00e-05 | 185 | 191 | 9 | int:LHX3 | |
| Interaction | BUB3 interactions | 7.68e-05 | 232 | 191 | 10 | int:BUB3 | |
| Interaction | TERF2IP interactions | CDK12 POGZ CIC TASOR2 NFRKB KNL1 ZEB1 E2F4 CHAMP1 SETD2 TJP1 PHF3 MDC1 SRRM2 SPEN CUX1 | 7.69e-05 | 552 | 191 | 16 | int:TERF2IP |
| Interaction | SHANK3 interactions | CTTNBP2 MAP1A NACA SYNPO SIRPA TASOR2 SYNJ1 PI4KA KIF2A SHANK1 AMPH NCKIPSD PRRT2 SETD2 MYO15A | 8.10e-05 | 496 | 191 | 15 | int:SHANK3 |
| Interaction | DCTN1 interactions | MAP1A NACA BBS4 ZNF207 CC2D1A TNIP1 CLIP1 LUZP1 TJP2 KIF2A HSF1 BAG3 MAP7D1 INAVA CEP170B | 8.28e-05 | 497 | 191 | 15 | int:DCTN1 |
| Interaction | KDM1A interactions | TNIP1 POGZ CEP76 PHF8 TRRAP CIC LUZP1 SYNJ1 SNX15 HSF1 KNL1 ZEB1 BAG3 E2F4 ZMIZ1 CHAMP1 PIAS2 BAHD1 MAP7D1 PDE4DIP ANKRD17 CUX1 | 8.85e-05 | 941 | 191 | 22 | int:KDM1A |
| Interaction | DUSP16 interactions | TNIP1 LUZP1 TASOR2 ARFGAP3 NYNRIN HELZ KNL1 PTPN23 FAM83H SMG8 | 9.17e-05 | 237 | 191 | 10 | int:DUSP16 |
| Interaction | NUP43 interactions | CDK12 POGZ PHF8 TASOR2 PRRC2C RBM19 PI4KA NFRKB KIF2A KNL1 E2F4 CHAMP1 SETD2 PBRM1 MDC1 SRRM2 SPEN | 9.94e-05 | 625 | 191 | 17 | int:NUP43 |
| Interaction | H3-4 interactions | BRPF3 TNIP1 POGZ PHF8 TRRAP REXO1 KMT2C PRRC2C KIF2A CHAMP1 SETD2 PBRM1 PHF3 H1-3 | 9.97e-05 | 448 | 191 | 14 | int:H3-4 |
| Interaction | RPA4 interactions | NACA ZNF207 POGZ TRRAP PRRC2C TJP2 KNL1 CHERP STMN1 CHAMP1 PIAS2 SETD2 TJP1 CUX1 | 1.09e-04 | 452 | 191 | 14 | int:RPA4 |
| Interaction | SOHLH1 interactions | 1.14e-04 | 115 | 191 | 7 | int:SOHLH1 | |
| Interaction | MAPRE1 interactions | SEPTIN9 SYNPO CLIP1 LUZP1 MAST4 PRRC2C KIF2A BAG3 FAM83H MAP7D1 GAS2L2 PDE4DIP SRRM2 POM121B CEP170B | 1.20e-04 | 514 | 191 | 15 | int:MAPRE1 |
| Interaction | LAT interactions | 1.27e-04 | 117 | 191 | 7 | int:LAT | |
| Interaction | H3C1 interactions | NACA ZKSCAN8 TNIP1 POGZ PHF8 KDM6B TRRAP KMT2C PRRC2C BIN2 HSF1 CHERP CHAMP1 SETD2 MAP7D1 PBRM1 PHF3 MDC1 H1-3 SPEN CUX1 | 1.35e-04 | 901 | 191 | 21 | int:H3C1 |
| Interaction | CAPZB interactions | BRPF3 MYLK NACA TNIP1 SYNPO SIRPA TRRAP CLIP1 CIC LUZP1 PER2 ARFGAP3 PRRC2C TJP2 KIF2A ZNF574 CARMIL1 BAG3 FAM83H TJP1 MDC1 ANKRD17 SOS1 | 1.57e-04 | 1049 | 191 | 23 | int:CAPZB |
| Interaction | BRPF3 interactions | 1.89e-04 | 166 | 191 | 8 | int:BRPF3 | |
| Interaction | LHX4 interactions | 1.89e-04 | 166 | 191 | 8 | int:LHX4 | |
| Interaction | CLDN2 interactions | 2.01e-04 | 31 | 191 | 4 | int:CLDN2 | |
| Interaction | SMC5 interactions | CDK12 SEPTIN9 MAZ ZNF207 POGZ CIC LUZP1 TASOR2 PRAM1 PRRC2C RBM19 NFRKB KNL1 CHERP CHAMP1 SETD2 TJP1 PHF3 MDC1 SRRM2 SPEN CUX1 | 2.10e-04 | 1000 | 191 | 22 | int:SMC5 |
| Interaction | DCAF7 interactions | BRPF3 CEP76 KDM6B CIC HSF1 ZNF574 SMARCAL1 NCKIPSD TJP1 KNDC1 MAST1 SRRM2 | 2.13e-04 | 368 | 191 | 12 | int:DCAF7 |
| Interaction | SH3KBP1 interactions | SEPTIN9 SYNPO PTK2B SYNJ1 TJP2 CARMIL1 SH3BP2 RPH3A MDC1 SRRM2 SOS1 | 2.18e-04 | 315 | 191 | 11 | int:SH3KBP1 |
| Interaction | BICD2 interactions | DOCK4 SEPTIN9 CC2D1A CLIP1 LUZP1 BFSP1 MAST4 SYNJ1 ARFGAP3 TJP2 PTPN23 TJP1 CEP170B | 2.23e-04 | 426 | 191 | 13 | int:BICD2 |
| Interaction | BIN1 interactions | 2.32e-04 | 129 | 191 | 7 | int:BIN1 | |
| Interaction | BAG2 interactions | BRPF3 TNIP1 CIC LUZP1 PRRC2C NFRKB HSF1 SPINDOC KNL1 BAG3 PTPN23 E2F4 SMG8 MDC1 SRRM2 SPEN | 2.99e-04 | 622 | 191 | 16 | int:BAG2 |
| Cytoband | 16p11.2 | 1.93e-06 | 191 | 197 | 8 | 16p11.2 | |
| Cytoband | 9q21.32 | 7.17e-05 | 19 | 197 | 3 | 9q21.32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | MYO9B CC2D1A DENND1C REXO1 PRAM1 CHERP STAP2 COL5A3 PRR22 JSRP1 KLF1 MAST1 | 1.89e-04 | 797 | 197 | 12 | chr19p13 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p11 | 2.14e-04 | 278 | 197 | 7 | chr16p11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p21 | 4.61e-04 | 316 | 197 | 7 | chr3p21 | |
| Cytoband | 16p12.2 | 5.43e-04 | 37 | 197 | 3 | 16p12.2 | |
| Cytoband | 1q12 | 6.47e-04 | 9 | 197 | 2 | 1q12 | |
| GeneFamily | PDZ domain containing | 6.95e-06 | 152 | 118 | 8 | 1220 | |
| GeneFamily | PHD finger proteins | 3.07e-04 | 90 | 118 | 5 | 88 | |
| GeneFamily | Zinc fingers MIZ-type | 8.68e-04 | 7 | 118 | 2 | 85 | |
| GeneFamily | E2F transcription factors | 1.15e-03 | 8 | 118 | 2 | 982 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.48e-03 | 9 | 118 | 2 | 1234 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF142 MAZ ZKSCAN8 ZNF207 REPIN1 ZNF469 ZNF398 ZNF574 ZEB1 CHAMP1 KLF1 ZFHX2 | 2.56e-03 | 718 | 118 | 12 | 28 |
| GeneFamily | N-BAR domain containing | 2.67e-03 | 12 | 118 | 2 | 1289 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOCK4 MYO9B SEPTIN9 NPIPB3 RNF13 PHF8 TRRAP CLIP1 GMPS HOXB2 PRRC2C TJP2 HELZ KIF2A ADAM17 MNT AMPH ZEB1 APBB2 E2F5 ZMIZ1 SETD2 PHF3 ANKRD17 SPEN CUX1 SOS1 | 2.94e-10 | 856 | 196 | 27 | M4500 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | ZNF142 MYO9B SEPTIN9 DENND1C TRRAP REPIN1 REXO1 PRAM1 HOXB2 PRR14 PI4KA CPNE1 MNT RHBDF2 RAPGEF1 E2F4 ZMIZ1 MAP7D1 SCAP LRP10 MDC1 SRRM2 SPEN CUX1 PPP1R12C | 2.00e-08 | 905 | 196 | 25 | M40865 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA | DOCK4 CTTNBP2 CHRNA4 PTK2B SEMA6D SYNJ1 GLRA2 NYAP1 CNGB1 AMPH SRCIN1 STMN1 PRRT2 SH3PXD2A PDE4DIP MAST1 ZFHX2 RIMS2 | 5.52e-08 | 506 | 196 | 18 | M39067 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | DOCK4 RNF13 POGZ NPIPB5 MAST4 PER2 HELZ KIF2A MNT E2F5 ZMIZ1 PHF3 MDC1 SPEN | 6.68e-08 | 300 | 196 | 14 | M8702 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | SEPTIN9 RNF13 NPIPB5 TRRAP CLIP1 GMPS PRRC2C TJP2 HELZ KIF2A ZMIZ1 SETD2 PHF3 ANKRD17 SPEN CUX1 SOS1 | 9.18e-08 | 466 | 196 | 17 | M13522 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | DOCK4 CTTNBP2 SIRPA CHRNA4 SEMA6D TULP4 GLRA2 CNGB1 AMPH CHERP PCLO SRCIN1 PRRT2 ASXL3 PDE4DIP MAST1 ZFHX2 RIMS2 | 6.21e-06 | 703 | 196 | 18 | M39070 |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | NPIPB3 KDM6B PER2 ARFGAP3 ADAM17 RCAN1 BAG3 ZMIZ1 SIM2 GTF2IRD1 BAHD1 RCAN3 SETD2 TJP1 PHF3 PDE4DIP FGD6 CUX1 SOS1 | 1.44e-05 | 822 | 196 | 19 | M6782 |
| Coexpression | GSE8515_CTRL_VS_IL1_4H_STIM_MAC_DN | 1.86e-05 | 197 | 196 | 9 | M5760 | |
| Coexpression | GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_DN | 2.01e-05 | 199 | 196 | 9 | M9418 | |
| Coexpression | JIANG_TIP30_TARGETS_DN | 2.87e-05 | 24 | 196 | 4 | M13930 | |
| Coexpression | CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP | NACA TNIP1 POGZ PRR14 PRRC2C PI4KA ZNF398 CACNA1D ZMIZ1 PRRT2 DENND1A SRRM2 | 3.59e-05 | 385 | 196 | 12 | M2840 |
| Coexpression | LAIHO_COLORECTAL_CANCER_SERRATED_DN | 4.34e-05 | 85 | 196 | 6 | M17423 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 6.61e-05 | 180 | 196 | 8 | M8239 | |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | SEPTIN9 POGZ CLIP1 REPIN1 KMT2C MAST4 ARFGAP3 TJP2 HELZ MNT RAPGEF1 GTF2IRD1 C8orf58 TJP1 SH3PXD2A MDC1 SETBP1 DEDD | 6.80e-05 | 843 | 196 | 18 | M2356 |
| Coexpression | ZHONG_PFC_C3_MICROGLIA | MAP1A CHRNA4 MAST4 GLRA2 AMPH SDK2 PCLO SRCIN1 PRRT2 GTF2IRD1 SH3PXD2A KNDC1 MAST1 | 8.46e-05 | 488 | 196 | 13 | M39104 |
| Coexpression | GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_DN | 8.72e-05 | 139 | 196 | 7 | M8948 | |
| Coexpression | GSE14413_UNSTIM_VS_IFNB_STIM_NIH3T3_CELLS_UP | 9.54e-05 | 141 | 196 | 7 | M466 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL | NPIPB4 TOX WNK2 AMPH PCLO TUT1 CDCP1 BAHD1 DCHS1 MAST1 ZFHX2 RIMS2 | 1.01e-04 | 429 | 196 | 12 | M45694 |
| Coexpression | GSE16385_IL4_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP | 1.11e-04 | 194 | 196 | 8 | M8017 | |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 1.14e-04 | 145 | 196 | 7 | M1810 | |
| Coexpression | GSE17301_CTRL_VS_48H_IFNA2_STIM_CD8_TCELL_DN | 1.20e-04 | 196 | 196 | 8 | M8034 | |
| Coexpression | GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN | 1.33e-04 | 199 | 196 | 8 | M6028 | |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_3H_DN | 1.33e-04 | 199 | 196 | 8 | M7711 | |
| Coexpression | GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_DN | 1.33e-04 | 199 | 196 | 8 | M5249 | |
| Coexpression | GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_DN | 1.33e-04 | 199 | 196 | 8 | M5257 | |
| Coexpression | GSE14769_20MIN_VS_360MIN_LPS_BMDM_DN | 1.37e-04 | 200 | 196 | 8 | M3513 | |
| Coexpression | GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_MAC_DN | 1.37e-04 | 200 | 196 | 8 | M5167 | |
| Coexpression | ZHONG_PFC_C7_ORG_UNDERGOING_NEURONAL_DIFFERENTIATION | 1.47e-04 | 67 | 196 | 5 | M39080 | |
| Coexpression | MARTENS_BOUND_BY_PML_RARA_FUSION | MYO9B SIRPA PLCG2 RHBDF2 SH3BP2 RAPGEF1 ZMIZ1 SH3PXD2A PDE4DIP INAVA TMEM143 CUX1 | 1.78e-04 | 456 | 196 | 12 | M2094 |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN | 1.86e-04 | 157 | 196 | 7 | M7733 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | DOCK4 NPIPB4 MYO9B NPIPB3 NPIPB5 KMT2C BRAF RAPGEF1 DENND1A ANKRD17 CUX1 | 1.11e-09 | 193 | 197 | 11 | 779276e775cb2492e8dd36436295a536084a6415 |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-08 | 150 | 197 | 9 | afd651c654e715414eff64cf3a37378d057a56a2 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.63e-08 | 174 | 197 | 9 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 2.82e-07 | 200 | 197 | 9 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | droplet-Thymus-nan-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-06 | 193 | 197 | 8 | 81871f4f2b63ca5f64a9ff12f6c909a34bf52216 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-06 | 194 | 197 | 8 | 66c056232ac216780acf4cc8ea325bd8ed1909c9 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-06 | 138 | 197 | 7 | c1a46fbf1beffa12c3d1b78361e0613e2e9e2d13 | |
| ToppCell | Adult-Immune|Adult / Lineage, Cell type, age group and donor | 2.93e-06 | 198 | 197 | 8 | 9bfd7b88aa646eaf5eddb15cf985c7ca910cb35e | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 3.15e-06 | 200 | 197 | 8 | bad32a95b759fad509401b07bc96a56687c2a592 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-06 | 142 | 197 | 7 | 67d4ff3483ae34f77c3325aa0fbd3462ca19ade4 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.49e-06 | 157 | 197 | 7 | 4766f7d545bf2d775390589460677519cb92f4d5 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal-Interneuron|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 9.46e-06 | 64 | 197 | 5 | fefabdf8d72a8f3caf78eb79d759edb475bdb2ad | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 9.72e-06 | 167 | 197 | 7 | 9efb9511a211d0824bb97f82c1a5860c43d2138f | |
| ToppCell | Cerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 9.72e-06 | 167 | 197 | 7 | 904c613aac3f9919a432b110bb1dcc832b5aec0a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-05 | 171 | 197 | 7 | 1854a777d9eb9d3fc3ed3632332a6f89ce8131da | |
| ToppCell | ICU-SEP-Myeloid-pDC|ICU-SEP / Disease, Lineage and Cell Type | 1.13e-05 | 171 | 197 | 7 | 72c448a0dc4c569bd6b465f9aa395f38034e7ea6 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.18e-05 | 172 | 197 | 7 | d65ffff3e341af34a043a0d802d7ba4b69de36e9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-05 | 173 | 197 | 7 | 4bc6d93716f093b460c8b047199db8cab5fea720 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-05 | 174 | 197 | 7 | 271c51d220842402975d97c86c9acfdbdf62a32c | |
| ToppCell | metastatic_Brain-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 1.47e-05 | 178 | 197 | 7 | 9a3581a0158dfa5a1cc942f8c532afb5e38b272a | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-05 | 178 | 197 | 7 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-05 | 181 | 197 | 7 | e0abf2707d9e0aa942c657eef7d2cbcd02f060dd | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.82e-05 | 184 | 197 | 7 | 102b6f621a5b551e622f97b12d787c080b052a72 | |
| ToppCell | cellseq-Epithelial-Epithelial_Neuro-Secretory-Tuft-Tuft|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.89e-05 | 185 | 197 | 7 | 1fbdc96da0623c3935ae9d29dcb4ba9c474e5c21 | |
| ToppCell | cellseq-Epithelial-Epithelial_Neuro-Secretory-Tuft|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.89e-05 | 185 | 197 | 7 | b45487daac116e3d3d65ac2b0f81d1bf7d1a1914 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-05 | 186 | 197 | 7 | f5468e03321ea2083e223eb0d92c3a9307039569 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.95e-05 | 186 | 197 | 7 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.95e-05 | 186 | 197 | 7 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 187 | 197 | 7 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | COVID-19_Severe-pDC|COVID-19_Severe / Disease condition and Cell class | 2.09e-05 | 188 | 197 | 7 | 475008f45673b42b75ef231c2df91f8b9adc9201 | |
| ToppCell | COVID-19_Severe-pDC-|COVID-19_Severe / Disease condition and Cell class | 2.09e-05 | 188 | 197 | 7 | 9fd1116e31a05554850b8ed3c005ea660dfbd51c | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 188 | 197 | 7 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 188 | 197 | 7 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.24e-05 | 190 | 197 | 7 | ed100e271aac82806f59e0c613ccda63f59100c1 | |
| ToppCell | (0)_Myeloid-(01)_Dendritic_cell|(0)_Myeloid / immune cells in Peripheral Blood (logTPM normalization) | 2.24e-05 | 190 | 197 | 7 | e9507bb0c8ff3d071402731a9b8cfe1bba93fab0 | |
| ToppCell | severe-Lymphocytic-CD4_T_cells_3|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.31e-05 | 191 | 197 | 7 | afff6bfae9a2f1e17d2731315e7fe63c4601679f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-05 | 191 | 197 | 7 | 963f4f2e852bbb4faf070aafb0d368297abacd3b | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|lung / Disease (COVID-19 only), tissue and cell type | 2.31e-05 | 191 | 197 | 7 | dab953682b8c9ed680a799161f837f792a7e4f33 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-05 | 193 | 197 | 7 | 12380713db6582749183a19de65d4af9d6469a3f | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-05 | 193 | 197 | 7 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-05 | 193 | 197 | 7 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-05 | 193 | 197 | 7 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.56e-05 | 194 | 197 | 7 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | facs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-05 | 194 | 197 | 7 | f1661f9f2439fca5c1012c693b0744c4e3b90a9b | |
| ToppCell | metastatic_Brain-Fibroblasts-Pericytes|metastatic_Brain / Location, Cell class and cell subclass | 2.56e-05 | 194 | 197 | 7 | d1889a3e22d5b88461c81ec3ea0e74bb9bf63e60 | |
| ToppCell | facs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-05 | 194 | 197 | 7 | cda1b197efb199330ea7ab25a7cee22cae22589d | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-05 | 194 | 197 | 7 | 52ecec2618c3bb5fdd7fb06b5a40bd6f0aedfe1d | |
| ToppCell | Immune-alveolar_macrophage_(MARCO_positive)|World / Lineage, Cell type, age group and donor | 2.64e-05 | 195 | 197 | 7 | f92114ef995e690a3bedc62c89c5fd6773d0d9f7 | |
| ToppCell | COVID-19-Myeloid-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations) | 2.73e-05 | 196 | 197 | 7 | 4929cfed1f150c1fde4d79cb49895c2ea467a18f | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-05 | 197 | 197 | 7 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|lung / Disease (COVID-19 only), tissue and cell type | 2.82e-05 | 197 | 197 | 7 | a0f8a992282a6d64890f5574c7c9741fcb38dadd | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 2.82e-05 | 197 | 197 | 7 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | Sepsis-URO-Others|URO / Disease, condition lineage and cell class | 2.91e-05 | 198 | 197 | 7 | 6caab5266da666cfbe92ac1ace26ad2004e5aa09 | |
| ToppCell | Fetal_29-31_weeks-Immune|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.91e-05 | 198 | 197 | 7 | 5dff131356b8c22743bd27b2b21f86ee6e4a0a0d | |
| ToppCell | Sepsis-URO-Others-RBC|URO / Disease, condition lineage and cell class | 2.91e-05 | 198 | 197 | 7 | d35e9d0952b3f7cd5d0d1a69bad2ae81af8eed50 | |
| ToppCell | Immune|World / Lineage, Cell type, age group and donor | 2.91e-05 | 198 | 197 | 7 | 65681b54d13c6997bd90a1c2a12314a80e964fe3 | |
| ToppCell | severe-pDC|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.91e-05 | 198 | 197 | 7 | 22da4a29b9ff8b94d98bc69b4632a2a58d5dd9e6 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 2.91e-05 | 198 | 197 | 7 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.91e-05 | 198 | 197 | 7 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | severe-pDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.91e-05 | 198 | 197 | 7 | 3c4820a8391088682fb3e47b914f872533bae227 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.91e-05 | 198 | 197 | 7 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | Immune-monocyte|World / Lineage, Cell type, age group and donor | 2.91e-05 | 198 | 197 | 7 | d3622da252fd580f1dc5c7478a8e23df5ec083cf | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.11e-05 | 200 | 197 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.11e-05 | 200 | 197 | 7 | 2f5b71e55c2de0e77fdae6667eb57f333acc6cd1 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.11e-05 | 200 | 197 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Monocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.11e-05 | 200 | 197 | 7 | fd72fe6565e2f4885481991492d58c323ab1ad40 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.11e-05 | 200 | 197 | 7 | 881ab995c90d75fd987d6e8f1f926a4bfcc4235f | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD14|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.11e-05 | 200 | 197 | 7 | b4277b6faa69f20974696c7c422311f5c89e3663 | |
| ToppCell | BAL-Control-cDC_4|Control / Compartment, Disease Groups and Clusters | 4.58e-05 | 145 | 197 | 6 | 3b2a2965dc18abd39d5ed70c0fcad0210e7f12c8 | |
| ToppCell | PBMC-Severe-cDC_3|Severe / Compartment, Disease Groups and Clusters | 5.96e-05 | 152 | 197 | 6 | 1a3f8ed476aa9a39742b4684be2c704669e4a3d0 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.64e-05 | 155 | 197 | 6 | a4ff78e2efc6fe9a513bb2b64e5848f2ce65a09f | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD8+_T_naive|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 6.64e-05 | 155 | 197 | 6 | e2c901d5c9e42d25d7702e5e8fc19b06f7c817be | |
| ToppCell | 10x5'-Lung-Lymphocytic_B-ABC_aged-B_memory|Lung / Manually curated celltypes from each tissue | 7.64e-05 | 159 | 197 | 6 | d3202ddc291b8686dbe67690df13c7daffec2199 | |
| ToppCell | URO-Other-RBC|URO / Disease, Lineage and Cell Type | 7.91e-05 | 160 | 197 | 6 | 558f3b0719e2461a69e1b93b08e21675e8d07a5a | |
| ToppCell | URO-Other|URO / Disease, Lineage and Cell Type | 7.91e-05 | 160 | 197 | 6 | b0923e6bacfaba8ca40aa5706bf270eea0938b0a | |
| ToppCell | E18.5-samps-Myeloid-Macrophage-macrophage_-_intermediate_-_unactivated|E18.5-samps / Age Group, Lineage, Cell class and subclass | 8.47e-05 | 162 | 197 | 6 | 60d3fe1f5cec4285b8774ff078ebcc6bfaec26ed | |
| ToppCell | E18.5-samps-Myeloid|E18.5-samps / Age Group, Lineage, Cell class and subclass | 8.47e-05 | 162 | 197 | 6 | 18e4a807e25f754a69e9eaaddfde40f8de9b8512 | |
| ToppCell | E18.5-samps-Myeloid-Macrophage|E18.5-samps / Age Group, Lineage, Cell class and subclass | 8.47e-05 | 162 | 197 | 6 | 0970e4eda60e3f015335e2726e6d565fb2f43372 | |
| ToppCell | IIF-Other-HSPC|IIF / Disease, Lineage and Cell Type | 8.76e-05 | 163 | 197 | 6 | 1e0d38fbed38ac48478868a1480172a1a3f7c1b7 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 9.06e-05 | 164 | 197 | 6 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.37e-05 | 165 | 197 | 6 | f80665b75d43f1bf6919d59fc762e7e0bac653f2 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Sphkap-Excitatory_Neuron.Gad1Gad2.Sphkap-Cpne4_(Basomedial_amygdaloid_nucleus_(BMA))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 9.50e-05 | 54 | 197 | 4 | 7670a6eb185ae0d8c3c0cb17f8eaa9970355187b | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Sphkap-Excitatory_Neuron.Gad1Gad2.Sphkap-Cpne4_(Basomedial_amygdaloid_nucleus_(BMA))-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 9.50e-05 | 54 | 197 | 4 | 79f804e73f859c0e8192d9e9e6ee2282f7f1691b | |
| ToppCell | 390C-Myeloid-Dendritic-pDC|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.03e-04 | 168 | 197 | 6 | 5a2e7a52b7330dce30823695a7b9b26bc47a69ce | |
| ToppCell | 343B-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-04 | 169 | 197 | 6 | 632aa3ab39ec87bafcefec6cddf71129a054d3b0 | |
| ToppCell | droplet-Heart-4Chambers-21m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 171 | 197 | 6 | e852d0e8589eecf4a2e5fea039b52a67c5d58dbd | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 171 | 197 | 6 | 99176a932569fa1c7e1c01009684f5a65244b96e | |
| ToppCell | 390C-Myeloid-Dendritic-pDC|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.33e-04 | 176 | 197 | 6 | aab9603b7943b7f7243eb6190ebba998566196f3 | |
| ToppCell | PBMC-Mild-cDC_11|Mild / Compartment, Disease Groups and Clusters | 1.38e-04 | 177 | 197 | 6 | 974305e4c0eff90134c4e58cf11b955d1eee0501 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.42e-04 | 178 | 197 | 6 | 0b59e3d75b143bd7bf91a7800a49699c51e68c5a | |
| ToppCell | 3'-Adult-Appendix-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.46e-04 | 179 | 197 | 6 | 2285e3a9018a60d7f6e974fee46b6f61d39aa76f | |
| ToppCell | 3'-Adult-Appendix-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.46e-04 | 179 | 197 | 6 | 0b0f27d7c5cc5ae7618d887dcfa7219df8ff1935 | |
| ToppCell | 3'-Adult-Appendix-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.46e-04 | 179 | 197 | 6 | 63bc819df62b1f8f37bf1f17bdd4fcc161886923 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD1c+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.55e-04 | 181 | 197 | 6 | cc7ae1221a28bc404138a7efee0ad08a19cc3d86 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.55e-04 | 181 | 197 | 6 | f6629fa71bb94405f523f63a9264cacf6d15c5f4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-04 | 181 | 197 | 6 | 22363c5835dd6cef8f895ab9362e0837d92b15b1 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-Pre-B|bone_marrow / Manually curated celltypes from each tissue | 1.60e-04 | 182 | 197 | 6 | a5fd392178c2f533e265d2e3ce63b90c2553e4c1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-04 | 182 | 197 | 6 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | IIH-Treg-proli_CD4|IIH / Condition, Cell_class and T cell subcluster | 1.60e-04 | 182 | 197 | 6 | 5c7d02da9ca2bca49db9832704b6894dfaa08a71 | |
| ToppCell | normal_Lung-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 1.60e-04 | 182 | 197 | 6 | 8dd79fef8f8463ad3194f9cc07c6cacf2c886304 | |
| Drug | Clobetasol propionate [25122-46-7]; Down 200; 8.6uM; MCF7; HT_HG-U133A | SEPTIN9 BFSP1 HOXB2 MAST4 SEMA6D RBM19 E2F4 TUT1 UBXN1 PDE4DIP CEP170B | 8.70e-07 | 197 | 190 | 11 | 6095_DN |
| Drug | carbamazepine; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | MYLK MAP1A CACNA1D APBB2 UBXN1 GRM1 SH3D21 PHF3 SETBP1 RIMS2 | 5.90e-06 | 195 | 190 | 10 | 919_UP |
| Drug | Thiamine hydrochloride [67-03-8]; Up 200; 11.8uM; MCF7; HT_HG-U133A | BFSP1 SYNJ1 RBM19 ADAM17 CACNA1D MED9 SH3BP2 TUT1 GRM1 RCAN3 | 6.17e-06 | 196 | 190 | 10 | 7479_UP |
| Drug | Picotamide monohydrate [80530-63-8]; Down 200; 10.2uM; PC3; HT_HG-U133A | 6.45e-06 | 197 | 190 | 10 | 2070_DN | |
| Drug | Iohexol [66108-95-0]; Up 200; 4.8uM; HL60; HT_HG-U133A | MYLK CNGB1 REM1 SH3BP2 GRM1 CDCP1 RPH3A SH3PXD2A PDE4DIP ZFHX2 | 7.06e-06 | 199 | 190 | 10 | 2461_UP |
| Drug | Mepenzolate bromide [76-90-4]; Up 200; 9.6uM; PC3; HT_HG-U133A | 3.12e-05 | 189 | 190 | 9 | 4304_UP | |
| Drug | Terbutaline hemisulfate [23031-32-5]; Down 200; 7.2uM; HL60; HG-U133A | 3.83e-05 | 194 | 190 | 9 | 1585_DN | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; PC3; HT_HG-U133A | 3.83e-05 | 194 | 190 | 9 | 4284_DN | |
| Drug | GSK-3 Inhibitor IX; Up 200; 0.5uM; MCF7; HT_HG-U133A | 3.83e-05 | 194 | 190 | 9 | 7044_UP | |
| Drug | Thalidomide [50-35-1]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 3.83e-05 | 194 | 190 | 9 | 2258_UP | |
| Drug | H-89, Dihydrochloride; Down 200; 0.5uM; PC3; HT_HG-U133A | 3.99e-05 | 195 | 190 | 9 | 6921_DN | |
| Drug | Cetirizine dihydrochloride [83881-52-1]; Down 200; 8.6uM; HL60; HT_HG-U133A | 3.99e-05 | 195 | 190 | 9 | 2468_DN | |
| Drug | Dimethadione [695-53-4]; Up 200; 31uM; HL60; HT_HG-U133A | 4.15e-05 | 196 | 190 | 9 | 3029_UP | |
| Drug | Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 4.15e-05 | 196 | 190 | 9 | 3256_UP | |
| Drug | Acacetin [480-44-4]; Up 200; 14uM; MCF7; HT_HG-U133A | 4.15e-05 | 196 | 190 | 9 | 3849_UP | |
| Drug | Methamphetamine | ZNF142 MYLK MAP1A ATXN7L1 RNF13 KDM6B CLIP1 ZC3H6 REXO1 CIC PER2 BRAF PRRC2C FOXE1 FAM193B CHERP TUT1 STMN1 GRM1 SLCO4C1 PDE4DIP KNDC1 LTK RIMS2 SRRM2 PRG4 CUX1 | 4.19e-05 | 1401 | 190 | 27 | ctd:D008694 |
| Drug | Ethamsylate [2624-44-4]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 4.32e-05 | 197 | 190 | 9 | 7335_DN | |
| Drug | Nefopam hydrochloride [23327-57-3]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 4.32e-05 | 197 | 190 | 9 | 3627_UP | |
| Drug | Todralazine hydrochloride [3778-76-5]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 4.32e-05 | 197 | 190 | 9 | 1677_UP | |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 4.32e-05 | 197 | 190 | 9 | 3639_DN | |
| Drug | Trioxsalen [3902-71-4]; Down 200; 17.6uM; MCF7; HT_HG-U133A | 4.32e-05 | 197 | 190 | 9 | 6078_DN | |
| Drug | Cefixime [79350-37-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 4.32e-05 | 197 | 190 | 9 | 3247_UP | |
| Drug | Flunarizine dihydrochloride [30484-77-6]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 4.49e-05 | 198 | 190 | 9 | 7013_UP | |
| Drug | (R) -Naproxen sodium salt [26159-34-2]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 4.49e-05 | 198 | 190 | 9 | 6096_DN | |
| Drug | Bemegride [64-65-3]; Down 200; 25.8uM; HL60; HT_HG-U133A | SEPTIN9 ZKSCAN8 CHRNA4 PRR14 ZEB1 APBB2 GTF2IRD1 PHF3 PDE4DIP | 4.49e-05 | 198 | 190 | 9 | 3051_DN |
| Drug | HA-1077 dihydrochloride; Up 200; 10uM; MCF7; HG-U133A | 4.49e-05 | 198 | 190 | 9 | 343_UP | |
| Drug | Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; MCF7; HT_HG-U133A | 4.49e-05 | 198 | 190 | 9 | 3883_DN | |
| Drug | Scopolamine hydrochloride [55-16-3]; Down 200; 11.8uM; HL60; HT_HG-U133A | 4.49e-05 | 198 | 190 | 9 | 3018_DN | |
| Drug | Dirithromycin [62013-04-1]; Up 200; 4.8uM; HL60; HG-U133A | 4.49e-05 | 198 | 190 | 9 | 1712_UP | |
| Drug | Gabazine [105538-73-6]; Up 200; 10.8uM; PC3; HT_HG-U133A | 4.49e-05 | 198 | 190 | 9 | 4236_UP | |
| Drug | Acenocoumarol [152-72-7]; Down 200; 11.4uM; PC3; HT_HG-U133A | 4.67e-05 | 199 | 190 | 9 | 2077_DN | |
| Drug | haloperidol; Up 200; 10uM; HL60; HT_HG-U133A | 4.67e-05 | 199 | 190 | 9 | 1185_UP | |
| Drug | wortmannin; Down 200; 0.01uM; HL60; HG-U133A | 4.67e-05 | 199 | 190 | 9 | 389_DN | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; PC3; HT_HG-U133A | 4.86e-05 | 200 | 190 | 9 | 3714_UP | |
| Drug | SBFI | 1.09e-04 | 30 | 190 | 4 | CID000123881 | |
| Drug | LY 294002; Up 200; 10uM; HL60; HT_HG-U133A | 1.62e-04 | 184 | 190 | 8 | 2696_UP | |
| Drug | Terbutaline hemisulfate [23031-32-5]; Up 200; 7.2uM; HL60; HG-U133A | 1.69e-04 | 185 | 190 | 8 | 1585_UP | |
| Drug | Thonzonium bromide [553-08-2]; Up 200; 6.8uM; MCF7; HT_HG-U133A | 1.81e-04 | 187 | 190 | 8 | 5678_UP | |
| Drug | 2-aminothiophenol | 2.07e-04 | 3 | 190 | 2 | ctd:C005464 | |
| Drug | Alcuronium | 2.07e-04 | 3 | 190 | 2 | ctd:D000443 | |
| Drug | Prochlorperazine dimaleate [84-02-6]; Down 200; 6.6uM; HL60; HT_HG-U133A | 2.17e-04 | 192 | 190 | 8 | 1286_DN | |
| Drug | Cyanocobalamin [68-19-9]; Down 200; 3uM; MCF7; HT_HG-U133A | 2.17e-04 | 192 | 190 | 8 | 4395_DN | |
| Drug | Cimetidine [51481-61-9]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 2.17e-04 | 192 | 190 | 8 | 4144_DN | |
| Drug | Chlorpromazine hydrochloride [69-09-0]; Up 200; 11.2uM; HL60; HT_HG-U133A | 2.25e-04 | 193 | 190 | 8 | 1864_UP | |
| Drug | Cefalonium [5575-21-3]; Down 200; 8.8uM; PC3; HT_HG-U133A | 2.25e-04 | 193 | 190 | 8 | 4245_DN | |
| Drug | Hycanthone [3105-97-3]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 2.25e-04 | 193 | 190 | 8 | 3229_DN | |
| Drug | 17-AAG; Up 200; 1uM; SKMEL5; HG-U133A | 2.33e-04 | 194 | 190 | 8 | 505_UP | |
| Drug | Harmol hydrochloride monohydrate [40580-83-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 2.33e-04 | 194 | 190 | 8 | 2900_DN | |
| Drug | Naringenine [480-41-1]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 2.33e-04 | 194 | 190 | 8 | 4422_DN | |
| Drug | Propoxycaine hydrochloride [550-83-4]; Down 200; 12uM; MCF7; HT_HG-U133A | 2.41e-04 | 195 | 190 | 8 | 3583_DN | |
| Drug | Famprofazone [22881-35-2]; Up 200; 10.6uM; PC3; HT_HG-U133A | 2.41e-04 | 195 | 190 | 8 | 4309_UP | |
| Drug | Cefamandole sodium salt [30034-03-8]; Down 200; 8.2uM; PC3; HT_HG-U133A | 2.41e-04 | 195 | 190 | 8 | 7394_DN | |
| Drug | Ebselen [60940-34-3]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 2.41e-04 | 195 | 190 | 8 | 3458_DN | |
| Drug | Securinine [5610-40-2]; Down 200; 18.4uM; MCF7; HT_HG-U133A | 2.41e-04 | 195 | 190 | 8 | 3470_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; HL60; HT_HG-U133A | 2.41e-04 | 195 | 190 | 8 | 2702_UP | |
| Drug | Riluzole hydrochloride; Down 200; 14.8uM; MCF7; HT_HG-U133A | 2.50e-04 | 196 | 190 | 8 | 4689_DN | |
| Drug | Benperidol [2062-84-2]; Down 200; 10.4uM; PC3; HT_HG-U133A | 2.50e-04 | 196 | 190 | 8 | 4196_DN | |
| Drug | Fluvoxamine maleate [61718-82-9]; Up 200; 9.2uM; HL60; HT_HG-U133A | 2.50e-04 | 196 | 190 | 8 | 2913_UP | |
| Drug | Meclocycline sulfosalicylate [73816-42-9]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 2.50e-04 | 196 | 190 | 8 | 4982_DN | |
| Drug | Ethaverine hydrochloride [985-13-7]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 2.50e-04 | 196 | 190 | 8 | 3375_UP | |
| Drug | Sulindac [38194-50-2]; Down 200; 11.2uM; HL60; HT_HG-U133A | 2.50e-04 | 196 | 190 | 8 | 1857_DN | |
| Drug | Spiramycin [8025-81-8]; Down 200; 4.8uM; PC3; HT_HG-U133A | 2.50e-04 | 196 | 190 | 8 | 3762_DN | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 2.50e-04 | 196 | 190 | 8 | 3422_DN | |
| Drug | Betazole hydrochloride; Up 200; 27uM; PC3; HT_HG-U133A | 2.50e-04 | 196 | 190 | 8 | 6344_UP | |
| Drug | Domperidone maleate; Down 200; 7.4uM; HL60; HT_HG-U133A | 2.50e-04 | 196 | 190 | 8 | 1301_DN | |
| Drug | 6-Hydroxytropinone [5932-53-6]; Up 200; 25.8uM; MCF7; HT_HG-U133A | 2.50e-04 | 196 | 190 | 8 | 7346_UP | |
| Drug | Meclofenamic acid sodium salt monohydrate [6385-02-0]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.50e-04 | 196 | 190 | 8 | 2291_DN | |
| Drug | Pyrithyldione [77-04-3]; Up 200; 24uM; HL60; HT_HG-U133A | 2.50e-04 | 196 | 190 | 8 | 2740_UP | |
| Drug | Trimipramine maleate salt [521-78-8]; Down 200; 9.8uM; PC3; HT_HG-U133A | 2.50e-04 | 196 | 190 | 8 | 4083_DN | |
| Drug | Corynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; PC3; HT_HG-U133A | 2.50e-04 | 196 | 190 | 8 | 4227_DN | |
| Drug | Thyroxine (L) [51-48-9]; Down 200; 5.2uM; HL60; HT_HG-U133A | 2.50e-04 | 196 | 190 | 8 | 1312_DN | |
| Drug | Deferoxamine mesylate [138-14-7]; Up 200; 6uM; PC3; HT_HG-U133A | 2.50e-04 | 196 | 190 | 8 | 4317_UP | |
| Drug | Naltrexone hydrochloride dihydrate [16676-29-2]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 2.59e-04 | 197 | 190 | 8 | 6241_UP | |
| Drug | Pentylenetetrazole [54-95-5]; Down 200; 29uM; PC3; HT_HG-U133A | 2.59e-04 | 197 | 190 | 8 | 2092_DN | |
| Drug | Sulfinpyrazone [57-96-5]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 2.59e-04 | 197 | 190 | 8 | 6230_DN | |
| Drug | Mesalamine [89-57-6]; Down 200; 26.2uM; MCF7; HT_HG-U133A | 2.59e-04 | 197 | 190 | 8 | 3584_DN | |
| Drug | Delsoline [509-18-2]; Down 200; 8.6uM; HL60; HT_HG-U133A | 2.59e-04 | 197 | 190 | 8 | 2513_DN | |
| Drug | Clofilium tosylate [92953-10-1]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 2.59e-04 | 197 | 190 | 8 | 6830_UP | |
| Drug | Hydroxyzine dihydrochloride [2192-20-3]; Down 200; 9uM; PC3; HG-U133A | 2.59e-04 | 197 | 190 | 8 | 1941_DN | |
| Drug | Fenspiride hydrochloride [5053-08-7]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 2.59e-04 | 197 | 190 | 8 | 2269_DN | |
| Drug | Carbachol [51-83-2]; Down 200; 21.8uM; HL60; HT_HG-U133A | 2.59e-04 | 197 | 190 | 8 | 3042_DN | |
| Drug | PNU-0251126 [267429-19-6]; Down 200; 1uM; PC3; HT_HG-U133A | 2.59e-04 | 197 | 190 | 8 | 7390_DN | |
| Drug | Dehydrocholic acid [81-23-2]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 2.59e-04 | 197 | 190 | 8 | 5681_UP | |
| Drug | Chloroquine diphosphate [50-63-5]; Down 200; 7.8uM; PC3; HT_HG-U133A | 2.67e-04 | 198 | 190 | 8 | 7251_DN | |
| Drug | Spectinomycin dihydrochloride [21736-83-4]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 2.67e-04 | 198 | 190 | 8 | 4773_DN | |
| Drug | Idoxuridine [54-42-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 2.67e-04 | 198 | 190 | 8 | 4785_DN | |
| Drug | beta- Belladonnine dichloroethylate [191355-47-2]; Down 200; 6uM; HL60; HT_HG-U133A | 2.67e-04 | 198 | 190 | 8 | 2164_DN | |
| Drug | Oxybenzone [131-57-7]; Up 200; 17.6uM; MCF7; HT_HG-U133A | 2.67e-04 | 198 | 190 | 8 | 5410_UP | |
| Drug | Flutamide [13311-84-7]; Up 200; 14.4uM; HL60; HT_HG-U133A | 2.67e-04 | 198 | 190 | 8 | 2358_UP | |
| Drug | Diazoxide [364-98-7]; Down 200; 17.4uM; MCF7; HT_HG-U133A | 2.67e-04 | 198 | 190 | 8 | 7168_DN | |
| Drug | 5149715; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 2.67e-04 | 198 | 190 | 8 | 890_DN | |
| Drug | Asiaticoside [16830-15-2]; Down 200; 4.2uM; HL60; HT_HG-U133A | 2.67e-04 | 198 | 190 | 8 | 2943_DN | |
| Drug | Torsemide [56211-40-6]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.67e-04 | 198 | 190 | 8 | 5476_DN | |
| Drug | Butirosin disulfate salt [51022-98-1]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 2.67e-04 | 198 | 190 | 8 | 6080_DN | |
| Drug | MK-886; Up 200; 1uM; MCF7; HG-U133A | 2.67e-04 | 198 | 190 | 8 | 601_UP | |
| Drug | minocycline; Down 200; 10.5uM; MCF7; HT_HG-U133A_EA | 2.67e-04 | 198 | 190 | 8 | 1135_DN | |
| Drug | Mafenide hydrochloride [138-37-4]; Up 200; 18uM; PC3; HT_HG-U133A | 2.67e-04 | 198 | 190 | 8 | 2124_UP | |
| Drug | Dimenhydrinate [523-87-5]; Up 200; 8.6uM; PC3; HT_HG-U133A | 2.67e-04 | 198 | 190 | 8 | 6352_UP | |
| Drug | Nabumetone [42924-53-8]; Up 200; 17.6uM; PC3; HT_HG-U133A | 2.67e-04 | 198 | 190 | 8 | 6327_UP | |
| Drug | Glycocholic acid [475-31-0]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 2.67e-04 | 198 | 190 | 8 | 5316_UP | |
| Disease | Intellectual Disability | ZNF142 RNF13 POGZ KDM6B TRRAP CIC KMT2C PTPN23 ZMIZ1 PRRT2 CHAMP1 SETD2 SETBP1 | 5.47e-06 | 447 | 185 | 13 | C3714756 |
| Disease | platelet measurement | 3.25e-05 | 315 | 185 | 10 | EFO_0005036 | |
| Disease | Abnormality of the urinary system | 3.91e-05 | 2 | 185 | 2 | C4021821 | |
| Disease | Down syndrome (implicated_via_orthology) | 1.04e-04 | 15 | 185 | 3 | DOID:14250 (implicated_via_orthology) | |
| Disease | centronuclear myopathy 2 (implicated_via_orthology) | 1.17e-04 | 3 | 185 | 2 | DOID:0111220 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 3.05e-04 | 93 | 185 | 5 | C1535926 | |
| Disease | platelet component distribution width | MYO9B SEPTIN9 SIRPA PRRC2C NYNRIN KIF2A PLCG2 NYAP1 CARMIL1 ZMIZ1 SETD2 ADAM33 FGD6 CUX1 | 3.12e-04 | 755 | 185 | 14 | EFO_0007984 |
| Disease | Attention Deficit Disorder | 3.42e-04 | 22 | 185 | 3 | C0041671 | |
| Disease | Minimal Brain Dysfunction | 3.42e-04 | 22 | 185 | 3 | C1321905 | |
| Disease | testosterone measurement | DOCK4 MAP1A MYO9B SEPTIN9 KDM6B REXO1 SEMA6D NYNRIN KNL1 CACNA1D MED9 CECR2 ZMIZ1 GTF2IRD1 CHAMP1 SH3PXD2A KNDC1 MYO15A SOS1 | 4.40e-04 | 1275 | 185 | 19 | EFO_0004908 |
| Disease | Attention deficit hyperactivity disorder | 4.45e-04 | 24 | 185 | 3 | C1263846 | |
| Disease | Malignant neoplasm of breast | TNIP1 CLIP1 CIC PER2 BRAF ARFGAP3 ZEB1 SMARCAL1 STMN1 ZMIZ1 SETD2 PBRM1 LBX1 SETBP1 ADAM33 SPEN CUX1 | 4.53e-04 | 1074 | 185 | 17 | C0006142 |
| Disease | Craniofacial Abnormalities | 4.67e-04 | 156 | 185 | 6 | C0376634 | |
| Disease | immature platelet count | 5.58e-04 | 106 | 185 | 5 | EFO_0803544 | |
| Disease | Cholangiocarcinoma | 5.67e-04 | 26 | 185 | 3 | C0206698 | |
| Disease | free androgen index | SEPTIN9 ZNF469 NYNRIN CACNA1D ZMIZ1 GTF2IRD1 SETD2 RIMS2 CUX1 | 6.24e-04 | 374 | 185 | 9 | EFO_0007005 |
| Disease | Sezary Syndrome | 6.35e-04 | 27 | 185 | 3 | C0036920 | |
| Disease | mean platelet volume | MYO9B CDK12 MAZ NACA SIRPA MAST4 PI4KA BIN2 KIF2A PLCG2 CARMIL1 ZMIZ1 PRRT2 SETD2 SETBP1 CUX1 | 7.34e-04 | 1020 | 185 | 16 | EFO_0004584 |
| Disease | immature platelet fraction | 7.76e-04 | 114 | 185 | 5 | EFO_0009187 | |
| Disease | cytotoxicity measurement, response to clozapine | 7.86e-04 | 29 | 185 | 3 | EFO_0006952, GO_0097338 | |
| Disease | Myeloid Leukemia, Chronic | 7.86e-04 | 29 | 185 | 3 | C0023473 | |
| Disease | alcohol consumption measurement | CTTNBP2 CDK12 NPIPB8 MAST4 SEMA6D NPIPB6 KIF2A ZNF574 CACNA1D RCAN1 PCLO STMN1 DENND1A RPH3A SETBP1 MYO15A RIMS2 CUX1 | 8.58e-04 | 1242 | 185 | 18 | EFO_0007878 |
| Disease | Alzheimer disease | ATXN7L1 TNIP1 PTK2B PRRC2C ADAM17 PLCG2 SRCIN1 CDCP1 MYO15A DEDD | 1.03e-03 | 485 | 185 | 10 | MONDO_0004975 |
| Disease | Noonan syndrome | 1.37e-03 | 9 | 185 | 2 | cv:C0028326 | |
| Disease | Autoinflammatory disorder | 1.37e-03 | 35 | 185 | 3 | C3860213 | |
| Disease | thyroid gland papillary carcinoma (is_implicated_in) | 1.70e-03 | 10 | 185 | 2 | DOID:3969 (is_implicated_in) | |
| Disease | response to carboplatin, response to antineoplastic agent | 1.70e-03 | 10 | 185 | 2 | GO_0097327, GO_0097328 | |
| Disease | Noonan Syndrome 1 | 2.07e-03 | 11 | 185 | 2 | C4551602 | |
| Disease | Turner Syndrome, Male | 2.07e-03 | 11 | 185 | 2 | C0041409 | |
| Disease | Female Pseudo-Turner Syndrome | 2.07e-03 | 11 | 185 | 2 | C1527404 | |
| Disease | pericalcarine cortex volume measurement | 2.07e-03 | 11 | 185 | 2 | EFO_0010322 | |
| Disease | Tremor | 2.07e-03 | 11 | 185 | 2 | C0040822 | |
| Disease | serum iron measurement | 2.13e-03 | 86 | 185 | 4 | EFO_0006332 | |
| Disease | Cutaneous Melanoma | 2.17e-03 | 41 | 185 | 3 | C0151779 | |
| Disease | Glioma | 2.22e-03 | 87 | 185 | 4 | C0017638 | |
| Disease | spleen volume | 2.49e-03 | 43 | 185 | 3 | EFO_0600047 | |
| Disease | eye color | 2.51e-03 | 90 | 185 | 4 | EFO_0003949 | |
| Disease | reticulocyte count | MYO9B SEPTIN9 SIRPA CLIP1 ZNF469 NFRKB C4B PLCG2 NYAP1 RPH3A KLF1 SETBP1 MAST1 ADAM33 CUX1 | 2.54e-03 | 1045 | 185 | 15 | EFO_0007986 |
| Disease | Seizures | 2.60e-03 | 218 | 185 | 6 | C0036572 | |
| Disease | hematologic cancer (implicated_via_orthology) | 2.91e-03 | 13 | 185 | 2 | DOID:2531 (implicated_via_orthology) | |
| Disease | Carcinogenesis | 2.91e-03 | 13 | 185 | 2 | C0596263 | |
| Disease | prostate cancer (is_marker_for) | 3.09e-03 | 156 | 185 | 5 | DOID:10283 (is_marker_for) | |
| Disease | unipolar depression, bipolar disorder | 3.09e-03 | 156 | 185 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | Adenocarcinoma of large intestine | 3.17e-03 | 96 | 185 | 4 | C1319315 | |
| Disease | white matter microstructure measurement | 3.34e-03 | 390 | 185 | 8 | EFO_0005674 | |
| Disease | corpus callosum volume measurement | 3.67e-03 | 100 | 185 | 4 | EFO_0010299 | |
| Disease | Replication Error Phenotype | 3.89e-03 | 15 | 185 | 2 | C1721098 | |
| Disease | Microsatellite Instability | 3.89e-03 | 15 | 185 | 2 | C0920269 | |
| Disease | RASopathy | 3.89e-03 | 15 | 185 | 2 | cv:C5555857 | |
| Disease | response to acetylsalicylate | 4.43e-03 | 16 | 185 | 2 | GO_1903492 | |
| Disease | congestive heart failure (biomarker_via_orthology) | 4.67e-03 | 107 | 185 | 4 | DOID:6000 (biomarker_via_orthology) | |
| Disease | FEV/FEC ratio | CTTNBP2 SPEF2 ARHGEF17 CACNA1D SH3BP2 BAG3 TUT1 GTF2IRD1 SH3D21 FAM83H SH3PXD2A ADAM33 MYO15A PRG4 FGD6 CUX1 | 4.71e-03 | 1228 | 185 | 16 | EFO_0004713 |
| Disease | Leukemia, Myelocytic, Acute | 4.79e-03 | 173 | 185 | 5 | C0023467 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 5.00e-03 | 17 | 185 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | non-alcoholic fatty liver disease, type 2 diabetes mellitus | 5.15e-03 | 110 | 185 | 4 | EFO_0003095, MONDO_0005148 | |
| Disease | Feeding difficulties | 5.60e-03 | 18 | 185 | 2 | C0232466 | |
| Disease | Nuclear non-senile cataract | 5.60e-03 | 18 | 185 | 2 | C1112705 | |
| Disease | Nuclear cataract | 5.60e-03 | 18 | 185 | 2 | C0392557 | |
| Disease | caudal middle frontal gyrus volume measurement | 5.60e-03 | 18 | 185 | 2 | EFO_0010290 | |
| Disease | schizophrenia, inflammatory bowel disease | 5.60e-03 | 18 | 185 | 2 | EFO_0003767, MONDO_0005090 | |
| Disease | response to methotrexate, juvenile idiopathic arthritis | 6.23e-03 | 19 | 185 | 2 | EFO_0002609, GO_0031427 | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 6.23e-03 | 19 | 185 | 2 | C3501846 | |
| Disease | primary ciliary dyskinesia (implicated_via_orthology) | 6.23e-03 | 19 | 185 | 2 | DOID:9562 (implicated_via_orthology) | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 6.23e-03 | 19 | 185 | 2 | C1843181 | |
| Disease | Cardio-facio-cutaneous syndrome | 6.23e-03 | 19 | 185 | 2 | C1275081 | |
| Disease | Costello syndrome (disorder) | 6.23e-03 | 19 | 185 | 2 | C0587248 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| APSKVPSPVPEAPFQ | 71 | A0A1B0GUX0 | |
| PPPPRPVADKDTSNE | 281 | P08173 | |
| HSAELPPPDQPSPCK | 516 | P43681 | |
| PSKSIPIPQPFRPAD | 336 | P15056 | |
| FTKPPSLPLEPEPAV | 491 | Q96RK4 | |
| SEKETPPPLPTIASP | 521 | Q9NYV4 | |
| TEPVKNSSPAPPQPA | 1076 | Q9NYV4 | |
| SCVVPPLSPPPKEED | 136 | Q9NP61 | |
| SQKVRPPPPPADSVT | 716 | Q92870 | |
| PAKDDPDAPLQPVTP | 1426 | P0C0L5 | |
| HTLVCSKPPPDNIPP | 1141 | Q8IZF6 | |
| AKLATEEPPPRSPPE | 786 | Q9H5V8 | |
| QPCPPIEASKDSKPP | 1076 | P39880 | |
| TSEPPPVPANKPKFL | 346 | P78314 | |
| ESPPEPPTLKPINDS | 851 | Q9ULD4 | |
| SSHPEKPLPAVSPDP | 786 | Q9BZ11 | |
| SPPKVEVPSANPPRL | 261 | Q8NAV2 | |
| TNPDEPPVAEQPKPL | 436 | Q8TAP6 | |
| LSDPEPRPPQPSKTV | 131 | O75618 | |
| VPPQEPDKPPANVAT | 756 | O75179 | |
| FEIPTKETPQPSQPP | 226 | Q9Y4F5 | |
| KETPQPSQPPEVPAH | 231 | Q9Y4F5 | |
| SPPESPQILAPTKPN | 711 | Q8IV53 | |
| TSLEVSPNPEPPEKP | 461 | Q9UBW5 | |
| TSQEEVPPHKPPTLP | 1466 | Q9BXF3 | |
| KKIPPAADSPLPSPA | 506 | Q9ULK2 | |
| LPPPLPNAEVPSDQK | 2041 | Q9C0F0 | |
| RIAKTPSPPEEPSPL | 256 | P49418 | |
| TPLPPSADDNLKTPP | 291 | Q92617 | |
| PPSAPPSADDNIKTP | 481 | Q92617 | |
| PPSAPPSADDNIKTP | 561 | Q92617 | |
| PPSAPPSADDNIKTP | 811 | Q92617 | |
| LAPPNPDKQFLISPP | 151 | P53805 | |
| PDKQFLISPPASPPV | 156 | P53805 | |
| PVKQFLISPPASPPV | 141 | Q9UKA8 | |
| PSQPKQPPKDSTTPE | 96 | Q9Y4C8 | |
| LPPKSQPPEKTEESP | 296 | Q15113 | |
| TIPREPPPSPAEVKF | 216 | Q86VS3 | |
| APLVKPLPVNPTDPA | 336 | Q9H3S7 | |
| TPLPPSADDNLKTPP | 291 | F8W0I5 | |
| PPSAPPSADDNIKTP | 731 | F8W0I5 | |
| PLAAPPSAEAKPPEA | 1031 | Q96PE2 | |
| SPAFPAPEDTVLLPP | 891 | Q96JQ0 | |
| LQKLGREPPSPPPSE | 2986 | Q96JQ0 | |
| KNPPPEFAKVSPCLP | 241 | O60684 | |
| EIPAVDPNFPNKPPL | 806 | Q86U86 | |
| VPPPKPATPDFRSVL | 971 | Q15746 | |
| CLPQLPEKASPPASP | 4291 | Q8NEZ4 | |
| EQAPPLPIKAPLPSA | 611 | Q7Z4F1 | |
| EQPEKEAQSPSPPHP | 2116 | P78559 | |
| TVPEAPAPPQKPLNS | 1041 | Q14676 | |
| KNPESTVPIAPELPP | 1361 | Q14676 | |
| EPSSPLPKFEAQAPP | 171 | Q96MG2 | |
| LPKFEAQAPPSAPPA | 176 | Q96MG2 | |
| PAIPISPPPVSAVNK | 731 | Q6P4R8 | |
| RSLPAEKPPAPEAQP | 2486 | Q9UKN7 | |
| PQPPLKEPFASLQSP | 721 | O15054 | |
| PRDPKVSAPPSILEP | 41 | P29376 | |
| SSPLVRVKEEPPSPP | 291 | Q00613 | |
| EFPPSPSNPTKEPVE | 6 | O15055 | |
| KQPPEADSLSKPAPP | 721 | Q9Y6V0 | |
| KPAPPKEPSVPSEQD | 731 | Q9Y6V0 | |
| PALNTLPPPKSPEDI | 796 | Q63HM2 | |
| PPSPLPPSVDDNLKT | 351 | E9PQR5 | |
| PLAASEASQPKPCPP | 1276 | P42356 | |
| TVDTAALKQPPAPPP | 121 | P56270 | |
| PQVPTPAPLLPDSKA | 141 | Q99583 | |
| PAPLLPDSKATIPPN | 146 | Q99583 | |
| IPQPHFSTDQPPLPK | 1466 | Q8NG31 | |
| TPLPPSADDNLKTPP | 291 | A8MRT5 | |
| PPSAPPSADDNIKTP | 481 | A8MRT5 | |
| PPSAPPSADDNIKTP | 561 | A8MRT5 | |
| PPSAPPSADDNIKTP | 936 | A8MRT5 | |
| LTDPVPNPNPHESKP | 631 | P16885 | |
| TPLPPSADDNLKTPP | 291 | C9JG80 | |
| PPSAPPSADDNIKTP | 481 | C9JG80 | |
| PPSAPPSADDNIKTP | 941 | C9JG80 | |
| LPDKVPSPESPASIP | 346 | Q8TDV0 | |
| PSPESPASIPEKEKP | 351 | Q8TDV0 | |
| PRPPPEQAKKSSDPL | 1906 | P42694 | |
| PKLSPEPQTPSLAPA | 1501 | Q9Y2H9 | |
| LPPTSDQPLPDTKPL | 16 | Q9NWA0 | |
| TEALSPPKTPNLLPP | 206 | A6NF01 | |
| SIKESTLIPPPPPFE | 36 | P14652 | |
| TPLPPSADDNLKTPP | 291 | E5RHQ5 | |
| PPSAPPSADDNIKTP | 401 | E5RHQ5 | |
| PPSAPPSADDNIKTP | 951 | E5RHQ5 | |
| KPLNPPASTAFPQEP | 261 | Q9BRQ0 | |
| SDQSESVRPPPPKPH | 516 | Q9UQ26 | |
| PETPPPPASSAKVNK | 76 | O00139 | |
| PDSQPTPKPALQPEL | 146 | Q7Z6L0 | |
| LKPKPNPPSPENTAS | 441 | Q5T0Z8 | |
| PPVKEPPTDVTPTFL | 566 | P49915 | |
| PALAPAPAPEPKALA | 151 | Q13351 | |
| AVSTPPPLPKPALAQ | 221 | Q16254 | |
| SKPVVFPVPPPDDLT | 236 | Q15329 | |
| SEPPALPPKPLAARS | 1926 | Q8N1I0 | |
| PAPAIPPTTQPDDSK | 366 | Q8IWX8 | |
| ENLPKSSSPQLPPKP | 601 | Q8WZ74 | |
| PAPRPPASLEVPSAK | 731 | Q96PV7 | |
| ELQTPLPSPEPSKPA | 166 | Q96JM3 | |
| FPEPAKTAPPASPEA | 531 | Q96JM3 | |
| KEPAAPLESSPQPPE | 846 | Q8NHY3 | |
| EPSPESPKPPLENGQ | 511 | Q12934 | |
| KASETPPPVAQPKPE | 116 | Q6P1N0 | |
| PAPKQELHQPSFPTP | 336 | Q8TBE0 | |
| TTITPEPEPKPQPNS | 676 | Q86V48 | |
| ATPANPLPQPPKDGD | 391 | P23416 | |
| APPQKEQPPAETPTD | 556 | Q3KQU3 | |
| EPSSSPQDPPKPVAA | 2171 | O15021 | |
| PTPEEQLPKTAPSPL | 461 | Q8TEH3 | |
| EEPPAAAPVSLPLPA | 306 | Q96G42 | |
| VELKPSVAPAPEPSP | 621 | Q76NI1 | |
| PVPAPPTKASALPVE | 781 | Q76NI1 | |
| PDSPSSPKVALLPPV | 1286 | Q5VZK9 | |
| DHLPPPANSNKPLTP | 21 | P52954 | |
| TPKILEPTAFQEPPP | 701 | Q14289 | |
| LKNQTAEPLPPEPPA | 286 | I6L899 | |
| KRESPSPKEPPQDNP | 116 | Q9Y6H8 | |
| VQPPPPDSPSIKDEA | 126 | Q6ZRV2 | |
| APKVPPQDLPPTATS | 236 | Q9UHL9 | |
| KLTPDDSPALTPPSP | 1136 | Q13255 | |
| PLAPTIPAPAEKTPV | 6 | P16402 | |
| VDSKPVSQKPPPPSE | 346 | O95817 | |
| ERVSLPEEPPTAPPQ | 681 | Q58EX2 | |
| PPDAPKLPENQTSPG | 581 | Q12770 | |
| EEESQVPKPPPESPA | 276 | Q3KP66 | |
| PSPLPPSVDDNLKTP | 331 | E9PJ23 | |
| FKVLTPAQPPPPSRE | 181 | A0A1B0GVH4 | |
| PSIPPASDTEKPLFP | 1716 | Q01668 | |
| TDIPKTETPAPNLPP | 286 | P25940 | |
| PSQPAAKEPSATPPI | 171 | P30622 | |
| PAKDDPDAPLQPVTP | 1426 | P0C0L4 | |
| LKPLPPSAKDPAQAP | 521 | Q99829 | |
| TPLPPSADDNLKTPP | 291 | A6NJU9 | |
| PPSAPPSADDNIKTP | 481 | A6NJU9 | |
| PPSAPPSADDNIKTP | 941 | A6NJU9 | |
| TEPAAPEVPLAPTKP | 581 | Q9P2P1 | |
| SPPIPPVHPDVQLKN | 136 | O75928 | |
| SLNPPTQKPSPAPDD | 51 | O75628 | |
| TKTTPCEIPPPFPNL | 316 | Q6ZVC0 | |
| KSTPAPAERPLPNPE | 6 | Q13239 | |
| PVFEPSTPDPAPAKN | 651 | Q8ND04 | |
| VGDLQPPPAKPASPA | 346 | Q8N1G1 | |
| SPVAIVPQPPKPGSE | 996 | Q9C093 | |
| ASSQDKLPPLPPLPN | 291 | Q9UGK3 | |
| VSEPAAPEQPAPEPK | 181 | Q9Y2J0 | |
| DSSPEPKALPQTPRP | 1481 | Q9UQ35 | |
| PHPSPKSPVQLEEAP | 401 | Q9BZL4 | |
| PSRIPEPESPAKPNV | 501 | Q9BZL4 | |
| PERPPAPENAPSSKK | 246 | A4FU49 | |
| ATPLPQKDPAQPLEP | 1091 | O43426 | |
| GPPPPQPEVLATVKE | 6 | O00358 | |
| EKAPAPQPPSLPDRS | 511 | Q8N3V7 | |
| LKQQLPPPTPSPDSA | 826 | Q7RTY7 | |
| IPALSPPTKVPEPNE | 441 | Q7Z3K3 | |
| ADIFLTPNKTPQPPP | 261 | Q9BWN1 | |
| AVSLKPPPPEVTDLP | 66 | Q96QH2 | |
| GISPPLAQSPPEVPK | 121 | Q9NZC9 | |
| VPPPIQPEAEKFPST | 1076 | Q9Y520 | |
| PRPKSPDLPNAASAP | 21 | Q5JR12 | |
| SKPENACEPIVPPPV | 71 | O43567 | |
| EPPASKVPEVPTAPA | 166 | Q9UHD8 | |
| PLVPSSSSPAKNPPE | 496 | Q14190 | |
| TPKQPAPKPEPSFSE | 481 | P78324 | |
| DPLPPQPVSPLDSKF | 216 | Q6ZUB0 | |
| QEKTPPPRPSPLEAG | 46 | Q9BUA3 | |
| TKPAPPSEDVPSAPL | 61 | Q13203 | |
| LDSPPAIPPRQPTSK | 1176 | Q07889 | |
| KPINPRPSLPPNSDT | 256 | Q92954 | |
| TPEKPAPTTPEELAP | 636 | Q92954 | |
| PEEPAPTTPKAAAPN | 661 | Q92954 | |
| PTTPKAAAPNTPKEP | 666 | Q92954 | |
| AAAPNTPKEPAPTTP | 671 | Q92954 | |
| SQVQPPPSKASAPEP | 256 | Q9NZQ3 | |
| AEPTPAVPLKPAQEP | 341 | Q9BWE0 | |
| ASPQPPPAVAAPSEK | 1136 | Q9Y566 | |
| PRSKESVPEFPLSPP | 26 | P16949 | |
| PAPVIPSAPAAPKLD | 741 | P78536 | |
| SPPLPPPAEERTSAK | 1246 | Q96RK0 | |
| ETPSLPTPIPLQPKE | 211 | Q14028 | |
| PPVPSQDDIPLSRPK | 21 | Q96Q45 | |
| DPPTARPTEPESPKN | 616 | Q15025 | |
| NKPPPVLITLPAEPT | 191 | Q8IZ63 | |
| AFIPTIKPPIPDPNN | 411 | Q9NRJ4 | |
| DPLPPQPVSPLDSKF | 216 | P0C874 | |
| QLRDNSPPPAFKPEP | 981 | Q9UDY2 | |
| QRATLDTVPPPPPSK | 1366 | Q7Z2Z1 | |
| PVPLPKPDPVSSINL | 886 | P61129 | |
| APVTPLAEPPTPEKD | 936 | Q9C0A1 | |
| EAPPALKAPPATTPA | 2196 | Q9C0A1 | |
| ESEPEKAPLCSVPPP | 1286 | O75970 | |
| TPDAKAAPTPTPAPV | 3236 | Q96T58 | |
| FPKLDPVAPITSEPP | 436 | Q96AN5 | |
| PPSSPQKLADVAAPP | 471 | Q9C0H9 | |
| SVQELAPPPALPPKQ | 601 | Q13905 | |
| KPQEPQKSPEPSLPS | 51 | Q6ZQN7 | |
| QKSPEPSLPSAPPNV | 56 | Q6ZQN7 | |
| LGFQLPKPPEPPSVE | 436 | Q5TCZ1 | |
| LEEPQPVPKAPESPS | 226 | Q9H6E5 | |
| LPPQPVSPLDSKFPI | 221 | Q6ZQQ2 | |
| LKQSSSPSPPEEPPA | 546 | Q9P2H5 | |
| PEVPVPFSSPPAAAK | 276 | Q8TD17 | |
| EAVPAEPSPKAPPLS | 106 | Q6ZN55 | |
| APPPIAPKPDIVISS | 26 | Q6ZV73 | |
| EVPVDPPPSSPAQEA | 171 | Q9NRS6 | |
| ETPESAPPIALPPDK | 1366 | Q92576 | |
| KPVPDEPPNPTNIEE | 171 | Q9NZQ9 | |
| PVPSSPSQEPPTKRE | 196 | Q04323 | |
| PNPPAVPLQVDSTPK | 101 | Q9BYW2 | |
| VTNNLLDLPPPSPPK | 2371 | Q9BYW2 | |
| VTPESKAPPPLPAAT | 891 | Q96JG9 | |
| DLKQPTQPPPLPAAE | 551 | P37275 | |
| TQPPPLPAAEAEKPE | 556 | P37275 | |
| TKPLPPPPTQTEEEE | 1241 | Q07157 | |
| ATVPAPQPPVTKPLF | 241 | O43670 | |
| TSSSPLPPPEPKQEA | 966 | Q9UPP1 | |
| ALNNFPKAIPPPTPD | 846 | Q5TAH2 | |
| PASSPEPPVPVKETR | 1401 | Q5VWN6 | |
| PLLEKPVSEPSTNPP | 756 | P52746 | |
| PLPPASPALPLQAVK | 846 | Q9Y3S1 | |
| DVPPKPSFVPQTPSV | 1051 | Q8NFY4 | |
| SRKPPNLSITIPPPE | 21 | Q6PJF5 | |
| PRAELPPPSEEPKTA | 731 | Q9Y6X0 | |
| EDFNIPPITPPSLPD | 66 | O94900 | |
| ATPVTPAPVPPFEKQ | 516 | Q9Y4A5 | |
| SLPPPKASPEKCDQP | 361 | Q9P2T0 | |
| RKPSAPSPPDQTPEE | 6 | Q15776 | |
| SPSQDVKPPFPPDIK | 531 | Q9ULJ6 | |
| PPKETPTPSVVNLPF | 881 | E9PAV3 | |
| PAVIPSSPKEVPATP | 1506 | E9PAV3 | |
| PEKEAPSPEKTLPPQ | 1116 | Q13459 | |
| PKLASLPQAPLPSAP | 1701 | Q5VU43 |